Date,Tweet,Ticker,Score
2020-04-09,burke herbert bank trust grows holdings,MRK,0.6405636072158813
2020-04-09,hexavest million position,MRK,0.242339625954628
2020-04-09,,MRK,0.5180692672729492
2020-04-09,embedded expectations analysis currently below corporate averages relative uafrs based uniform earnings uniform these levels rqznzktzgq equity,MRK,-0.8025517463684082
2020-04-09,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-04-09,adviser investments raises position,MRK,0.4072374403476715
2020-04-09,pembrolizumab receives priority review patients high tumour mutuation burden regardless tumour type,MRK,0.4462927877902984
2020-04-09,check latest oncology update ziilxwnpzy,MRK,0.2208184748888015
2020-04-10,peak profit expired option alerts,MRK,0.2009282559156417
2020-04-10,months option alerts peaked above after were triggered algo rckjicedhb,MRK,0.919970154762268
2020-04-10,view historical options performance ridkfjhvbk,MRK,0.0985150188207626
2020-04-10,sold uncommon cents,MRK,-1.0291588306427002
2020-04-10,acquired cypress wealth services,MRK,0.3651784360408783
2020-04-10,carroll financial associates million holdings,MRK,0.1196251884102821
2020-04-10,sold mission wealth management fjjycsqugz,MRK,-0.8118768930435181
2020-04-10,uptrend moving average convergence divergence macd histogram turned positive view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.960663914680481
2020-04-10,given consensus rating brokerages ztcmkmgvyn,MRK,0.8550620079040527
2020-04-10,brokerages target,MRK,0.0958971008658409
2020-04-10,brokerages target,MRK,0.0958971008658409
2020-04-11,options maxpain chart free options,MRK,0.1562585085630417
2020-04-11,recommendation hold rating,MRK,-0.1933444291353225
2020-04-11,explore fundamental numbers pros cons,MRK,-0.2624247074127197
2020-04-11,upcoming event april vaccines options expiring april cover event implied move,MRK,0.2294777333736419
2020-04-11,wealthtrust axiom sells,MRK,-0.7598159313201904
2020-04-11,uptrend moving average convergence divergence macd histogram turned positive view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.960663914680481
2020-04-11,alpha cubed investments buys,MRK,0.2398673444986343
2020-04-12,wealth advisors lowers stake,MRK,-0.4029102623462677
2020-04-12,receives average recommendation analysts,MRK,0.84912109375
2020-04-12,given average rating brokerages,MRK,0.8412586450576782
2020-04-12,first informative pivot points close pivot point download free tradingview stockstowatch,MRK,0.8902355432510376
2020-04-12,sold churchill management corp,MRK,-0.8807568550109863
2020-04-12,uptrend moving average convergence divergence macd histogram turned positive view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.960663914680481
2020-04-12,gillespie robinson grimm acquires,MRK,0.2287644743919372
2020-04-13,jacobs boosts stake oumwldnrno,MRK,0.2649970352649688
2020-04-13,practice friday,MRK,-0.2823741436004638
2020-04-13,about latest update oncology fhaerpwjeu,MRK,0.3583715856075287
2020-04-13,endometriosis pain trial using gefapixant shows clincally rmeaningful signal huge gnrh agonists problematic mechanism osteoporosis risk antagonists equally worrisome,MRK,-0.9509284496307372
2020-04-13,target analysts group drlvdimgjy,MRK,-1.0126184225082395
2020-04-13,target analysts group,MRK,-0.9554266929626464
2020-04-13,target analysts group,MRK,-0.9554266929626464
2020-04-13,lowered group,MRK,-0.9357736110687256
2020-04-13,showing depressed short medium rank relative higher long term outlook,MRK,-1.0732465982437134
2020-04-13,pdufa date link calendar,MRK,0.1528167426586151
2020-04-13,astrazeneca announce koselugo approved pediatric patients years older,MRK,0.2085656374692917
2020-04-13,koselugo selumetinib approved pediatric patients years older neurofibromatosis type,MRK,0.2282748371362686
2020-04-13,straddle implies move vaccines,MRK,0.2590605616569519
2020-04-13,astrazeneca announce koselugo approved pediatric patients years older symptomatic inoperable,MRK,0.2021813541650772
2020-04-13,about latest update oncology fhaerpwjeu,MRK,0.2962027788162231
2020-04-13,koselugo approved pediatric patients years older neurofibromatosis type symptomatic inoperable plexiform goxmrzfhqv,MRK,0.1848265826702118
2020-04-13,lowered svvqcmocgb,MRK,-1.030652403831482
2020-04-13,directional bias report click details,MRK,-0.7779198884963989
2020-04-13,report click sell,MRK,0.2802823483943939
2020-04-13,uptrend moving average convergence divergence macd histogram turned positive view odds indicators ceptajohed stockmarket technicalanalysis money daytrading news,MRK,0.960663914680481
2020-04-13,rexahnpharmaceuticals terminates breast cancer study baczsqqykn,MRK,-0.6052781343460083
2020-04-13,sanders morris harris sells,MRK,-0.5278066396713257
2020-04-14,purchased stolper,MRK,0.2374571561813354
2020-04-14,sold salem capital management caxbjlrqgo,MRK,-0.7794661521911621
2020-04-14,chart almost ready,MRK,0.7500708103179932
2020-04-14,hump,MRK,-0.0541131645441055
2020-04-14,flirting resistance heavy eyes gang dralyvvbcf,MRK,-0.9960793256759644
2020-04-14,making deeper wider moat people cancer treatments another,MRK,0.1743606626987457
2020-04-14,fallen well looking forward climbing someday better than were glta,MRK,0.9656447172164916
2020-04-14,recent technical alerts upper bollinger band walk,MRK,0.0150048844516277
2020-04-14,sprifermin increases cartilage thickness reduces loss knee,MRK,-0.5416650772094727
2020-04-14,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news keputwdbpx,MRK,0.9489938020706176
2020-04-14,sentiment total scores positive negative sentiment,MRK,-0.0440361015498638
2020-04-14,target lowered group,MRK,-0.9270496368408204
2020-04-14,target lowered group qwhrrgddze,MRK,-0.9270496368408204
2020-04-14,target lowered group,MRK,-0.9270496368408204
2020-04-14,target lowered group,MRK,-0.9270496368408204
2020-04-14,truewealth lowers position,MRK,-0.5985605716705322
2020-04-14,oversold taownpntdh,MRK,-0.8839130401611328
2020-04-14,howland capital management sells,MRK,-0.7166825532913208
2020-04-14,deprince race zollo increases stake,MRK,0.799537181854248
2020-04-14,louisiana state employees retirement system million position,MRK,0.1233606040477752
2020-04-14,honorable mentions juliegmd bush director came back play role johnshopkinssph clade game czars vagelos strong peterkolchinsky rtnarch step aside arch uznisrplto,MRK,0.8146466016769409
2020-04-15,jonathanrockoff launches herceptin biosimilar named ontruzant listed discount branded drug,MRK,0.1832518875598907
2020-04-15,zacks brokerages expect announce earnings,MRK,0.281205415725708
2020-04-15,zacks brokerages expect announce earnings,MRK,0.281205415725708
2020-04-15,zacks brokerages expect announce earnings,MRK,0.3684892654418945
2020-04-15,holdings raised baldwin brothers,MRK,0.5370640754699707
2020-04-15,jimcramer long true,MRK,0.8702493906021118
2020-04-15,learn about latest oncology news,MRK,0.3423519730567932
2020-04-15,semodough syinvesting gefapixant trial read june done recruitment sure what guidance eozdeifjcv,MRK,-0.0862189829349517
2020-04-15,waiting turn around change recently,MRK,0.174022227525711
2020-04-15,jacobplieth free action,MRK,0.7652591466903687
2020-04-15,biostocks announces launch ontruzant biosimilar herceptin ontruzant list single dose vial,MRK,0.1574045419692993
2020-04-15,what makes pharma tick april,MRK,0.0088699720799922
2020-04-15,what makes pharma tick april stockmarket economy,MRK,0.0201359316706657
2020-04-15,only hair dresser knows sure,MRK,0.1051445081830024
2020-04-15,history tends repeat itself know report,MRK,0.6846514940261841
2020-04-15,drop time pick,MRK,-1.0647900104522705
2020-04-15,nedpagliarulo samsung bioepis launching herceptin biosimilar discount brand,MRK,0.1657551676034927
2020-04-15,sentiment total scores positive negative sentiment,MRK,-0.0431540682911872
2020-04-15,estimates lowered leerink,MRK,-0.8594070672988892
2020-04-15,estimates lowered leerink,MRK,-0.8594070672988892
2020-04-15,estimates lowered leerink,MRK,-0.9525419473648072
2020-04-15,announces launch ontruzant trastuzumab dttb biosimilar herceptin trastuzumab,MRK,0.1133704483509063
2020-04-15,announces launch ontruzant trastuzumab dttb biosimilar herceptin trastuzumab pzakdeisqe,MRK,0.1133704483509063
2020-04-15,free action,MRK,0.7413638830184937
2020-04-15,launches herceptin biosimilar,MRK,0.0748028010129928
2020-04-15,announces launch ontruzant biosimilar herceptin ontruzant list single dose vial multiple dose vial,MRK,0.1708765923976898
2020-04-15,learn about latest oncology news,MRK,0.30426687002182
2020-04-15,group lowers target,MRK,-0.4892232120037079
2020-04-15,group lowers target,MRK,-0.4892232120037079
2020-04-15,group lowers target,MRK,-0.4892232120037079
2020-04-15,group lowers target,MRK,-0.7092818021774292
2020-04-15,group lowers target,MRK,-0.4892232120037079
2020-04-15,moving average moved above moving average april view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9106823205947876
2020-04-15,financial services grows position,MRK,0.6485590934753418
2020-04-15,hennessy advisors increases position,MRK,0.8852276802062988
2020-04-15,shilanski associates sells,MRK,-0.7235465049743652
2020-04-15,asset management corp sells,MRK,-0.7318311929702759
2020-04-16,ballast advisors holdings,MRK,0.1287561058998108
2020-04-16,first informative pivot points close pivot point download free tradingview stockstowatch,MRK,0.8716952800750732
2020-04-16,triggering alerts slow mover really long term,MRK,0.9090304374694824
2020-04-16,nice,MRK,0.9318573474884032
2020-04-16,earnings leerink forecasts,MRK,0.4925800561904907
2020-04-16,earnings leerink forecasts,MRK,0.3582043945789337
2020-04-16,delta expiration maxpain options crbzwxexdr,MRK,-0.0167825557291507
2020-04-16,uptrend jump because broke lower bollinger band march view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.940142035484314
2020-04-16,announces launch ontruzant trastuzumab dttb biosimilar herceptin trastuzumab,MRK,0.0276568233966827
2020-04-16,expected earnings,MRK,0.3858420252799988
2020-04-16,expected earnings wkmayxrqhq,MRK,0.3858420252799988
2020-04-16,expected earnings,MRK,0.3858420252799988
2020-04-16,launches latest herceptin knockoff harvard spinout grabs seed round,MRK,0.3465863764286041
2020-04-16,zacks brokerages expect announce earnings,MRK,0.4000797569751739
2020-04-17,corporate spin offs interesting fridayreads stayhomestayupdated,MRK,0.9727075099945068
2020-04-17,bought nwam,MRK,0.7494176626205444
2020-04-17,option order flow sentiment turned bearish bullish,MRK,-0.9003134965896606
2020-04-17,winner another lucky winner,MRK,0.9624741077423096
2020-04-17,guess know were close,MRK,-0.0917158722877502
2020-04-17,because fundamental reasons,MRK,-0.7355860471725464
2020-04-17,hanging around high what thoughts direction coming days,MRK,0.849494218826294
2020-04-17,forecasted earnings,MRK,0.385406881570816
2020-04-17,expected earn earnings,MRK,0.3290565013885498
2020-04-17,forecasted earnings hbpiueimku,MRK,0.385406881570816
2020-04-17,earnings leerink forecasts,MRK,0.3361362814903259
2020-04-17,zacks brokerages expect announce sales billion,MRK,0.0640686005353927
2020-04-17,moving average crossed above moving average april view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8968733549118042
2020-04-17,zacks brokerages anticipate announce sales billion,MRK,0.0831973031163215
2020-04-17,zacks brokerages anticipate announce sales billion,MRK,0.0831973031163215
2020-04-17,ended thursday gaining current marketcap current dividend yield earnings before stockmarket opens wallstreet high estimate mean estimate estimate investingnews,MRK,0.8157176971435547
2020-04-18,datatrials phase immunobridging study valent human papillomavirus vaccine chinese females years,MRK,-0.0189870558679103
2020-04-18,datatrials phase phase combination avelumab advanced small cell lung cancer estimated,MRK,0.2930653989315033
2020-04-18,datatrials phase bioequivalence study coated cesol tablet formulation versus biltricide estimated primary compl,MRK,-0.0290934592485427
2020-04-18,coming frequently conversations sense growing appreciation risk company guidance particularly china gardasil animal health covid while debate about potential impact magnitude keytruda,MRK,-1.0394036769866943
2020-04-18,phase immunobridging study valent human papillomavirus vaccine chinese females years estimated primary completion date,MRK,-0.0170655399560928
2020-04-18,phase phase combination avelumab advanced small cell lung cancer estimated primary completion date,MRK,0.5006834268569946
2020-04-18,phase bioequivalence study coated cesol tablet formulation versus biltricide estimated primary completion date,MRK,-0.0220033638179302
2020-04-18,zacks analysts anticipate earnings,MRK,0.2660569846630096
2020-04-18,tekmunnee rejection strength demark sell setup perfection trigger triggered cros,MRK,0.2689613997936249
2020-04-18,zacks analysts anticipate earnings,MRK,0.2660569846630096
2020-04-18,unicorn rating,MRK,0.3294529616832733
2020-04-18,recommendation hold rating,MRK,-0.1215898618102073
2020-04-18,technical alerts resistance pocket pivot,MRK,-0.0668964684009552
2020-04-18,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-04-18,estimates boosted analyst,MRK,0.812620997428894
2020-04-18,estimates boosted analyst,MRK,0.7111498117446899
2020-04-18,estimates boosted analyst,MRK,0.7111498117446899
2020-04-18,estimates boosted analyst,MRK,0.7111498117446899
2020-04-18,rejection strength demark sell setup perfection trigger triggered crossovers combo stockstotrade stockstowatch optionstrading optionsscalping,MRK,0.9284861087799072
2020-04-19,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators dvbxcotvvw stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-04-19,single point partners acquires,MRK,0.2390948683023452
2020-04-19,welch forbes grows stake clphiqagtn,MRK,0.2869513034820556
2020-04-19,pinnacle financial partners buys,MRK,0.251966655254364
2020-04-19,peak profit expired option alerts,MRK,0.5009063482284546
2020-04-19,calls option volume volume,MRK,0.8734750747680664
2020-04-19,months option alerts peaked above after were triggered algo qgtedeouul,MRK,0.923141598701477
2020-04-19,view historical options performance fklrqutimd,MRK,0.0985150188207626
2020-04-19,semodough coming frequently conversations sense growing appreciation risk,MRK,-1.0227656364440918
2020-04-19,implied volatility expiration maxpain options,MRK,-1.0676428079605105
2020-04-19,advisors purchases,MRK,0.1835841089487075
2020-04-20,northstar asset management raises holdings,MRK,0.5948518514633179
2020-04-20,puts option alert puts sweep near earnings before open sweeps,MRK,0.355149894952774
2020-04-20,stockonomist billion pharmaceutical company dddd clinical trials dddd thera,MRK,0.155029147863388
2020-04-20,billion pharmaceutical company dddd clinical trials dddd therapeutic combination keytruda signed vaccine deal dddd,MRK,0.392354279756546
2020-04-20,good time hook,MRK,0.7747666835784912
2020-04-20,toes water,MRK,0.4956548810005188
2020-04-20,nice volume beat volume steady,MRK,0.9866535663604736
2020-04-20,nice smooth,MRK,0.947547435760498
2020-04-20,realwillmeade million dark pool print bought,MRK,-0.0672242939472198
2020-04-20,million dark pool print bought,MRK,0.1855551898479461
2020-04-20,performing change recently,MRK,0.1855906993150711
2020-04-20,notes adding pharma growth however below earnings multiples read,MRK,0.8095462322235107
2020-04-20,earnings ratios bill alpert writes edition barron after lagging behind lilly outperformed index since coronavirus disruption began author,MRK,-1.0291703939437866
2020-04-20,phase survivac checkpoint inhibitor dlbcl estimated primary completion date,MRK,-0.0461990796029567
2020-04-20,phase study pembrolizumab maintenance first line platinum based chemotherapy patients metastatic squamous small cell lung cancer snsclc estimated primary completion date,MRK,0.0560216382145881
2020-04-20,phase pembrolizumab chemoradiation treatment advanced cervical cancer estimated primary completion date,MRK,0.5309668779373169
2020-04-20,phase neoadjuvant pembrolizumab paclitaxel followed epirubicin cyclophosphamide tnbc estimated primary completion date,MRK,-0.0166521742939949
2020-04-20,phase comparative study determine efficacy safety tolerability ceftolozane tazobactam estimated primary completion date,MRK,0.2153631299734115
2020-04-20,phase save valent vaccine high grade anal dysplasia estimated primary completion date,MRK,0.3138936460018158
2020-04-20,phase study pembrolizumab without platinum based combination chemotherapy versus chemotherapy alone urothelial carcinoma keynote estimated primary completion date,MRK,-0.0148159451782703
2020-04-20,real crowd pleasure glta,MRK,0.9910995960235596
2020-04-20,indication gathering into revenue reporting tear earnings,MRK,0.9413005113601683
2020-04-20,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-04-20,peak profit expired option alerts ohtgnxhbql,MRK,0.5009063482284546
2020-04-20,months option alerts peaked above after were triggered algo,MRK,0.923141598701477
2020-04-20,view historical options performance papudbqblk,MRK,0.0985150188207626
2020-04-20,darmstadt germany awarded second patent crispr gene editing technology,MRK,-0.0162564516067504
2020-04-20,darmstadt germany awarded second patent crispr gene editing technology,MRK,-0.0263014510273933
2020-04-21,sumitomo mitsui asset management company grows position,MRK,0.6065719127655029
2020-04-21,nominates risa lavizzo mourey professor population health health equity university pennsylvania board corpgov,MRK,0.0249946117401123
2020-04-21,hardly came deviation band being constant resistance continued drive lower,MRK,-1.0675429105758667
2020-04-21,thought business looked saving lives,MRK,0.7232422828674316
2020-04-21,kgaa opening gene ther carls bigpharma,MRK,-1.0165759325027466
2020-04-21,sector stink picked turn triple dividend,MRK,-1.0301417112350464
2020-04-21,crashes closing lower sentiment bearish,MRK,-1.0825109481811523
2020-04-21,boston trust walden corp decreases stake,MRK,-0.8706814050674438
2020-04-21,,MRK,-0.9444359540939332
2020-04-21,idorsia rival insomnia drug clears phase test daridorexant compete insomnia drug both make uaaibhbhxs,MRK,-0.0642591565847396
2020-04-21,baugh associates sells,MRK,-0.7123727798461914
2020-04-21,expands program amid pandemic disruptions,MRK,0.0439393222332
2020-04-21,marketcurrents expands program amid pandemic disruptions,MRK,-0.0096569769084453
2020-04-21,expands program amid pandemic disruptions,MRK,0.0051764920353889
2020-04-21,datatrials phase study pembrolizumab without platinum based combination chemotherapy versus chemotherapy alone,MRK,0.0212846212089061
2020-04-21,datatrials phase save valent vaccine high grade anal dysplasia estimated primary completion date,MRK,0.6102234125137329
2020-04-21,datatrials phase neoadjuvant pembrolizumab paclitaxel followed epirubicin cyclophosphamide tnbc,MRK,-0.0115571841597557
2020-04-21,datatrials phase pembrolizumab chemoradiation treatment advanced cervical cancer estimated primary complet,MRK,0.8162316083908081
2020-04-21,datatrials phase study pembrolizumab maintenance first line platinum based chemotherapy patients metastati,MRK,0.2939337790012359
2020-04-21,datatrials phase survivac checkpoint inhibitor dlbcl estimated primary completion date,MRK,-0.045473176985979
2020-04-21,chitraders broadens patient support assistance programs part overall covid relief efforts,MRK,0.90962016582489
2020-04-21,broadens patient support assistance programs part overall covid relief efforts,MRK,0.9312857389450072
2020-04-21,broadens patient support assistance programs part overall covid relief efforts,MRK,0.931719183921814
2020-04-21,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-04-21,announce earnings tuesday,MRK,0.0443972796201705
2020-04-21,announce earnings tuesday,MRK,0.0443972796201705
2020-04-21,announce earnings tuesday,MRK,0.0547903627157211
2020-04-21,announce earnings tuesday,MRK,0.0443972796201705
2020-04-21,expected earnings,MRK,0.3585638999938965
2020-04-21,zacks analysts expect announce sales billion,MRK,0.0867851376533508
2020-04-22,peak profit expired option alerts biuvylopsl,MRK,0.5009063482284546
2020-04-22,months option alerts peaked above after were triggered algo,MRK,0.923141598701477
2020-04-22,view historical options performance,MRK,0.0985150188207626
2020-04-22,founders capital management lowers stake,MRK,-0.3906145393848419
2020-04-22,wall street unbelievable reap stink unfair bots need shut,MRK,-1.074281930923462
2020-04-22,oliver luxxe assets million stake,MRK,0.2310172617435455
2020-04-22,wear mask optional,MRK,-0.0592123493552207
2020-04-22,honey hole better first,MRK,0.1723738610744476
2020-04-22,paydirt thru money maker washed gold nuggets batch,MRK,0.3744752705097198
2020-04-22,stalled lets hole,MRK,-0.3508122563362121
2020-04-22,hump treats,MRK,0.1126637607812881
2020-04-22,bull corner,MRK,-0.0266984142363071
2020-04-22,pull back foolish powered same usual helps boys make billions smart understand years chart shows glta,MRK,0.9371192455291748
2020-04-22,reason think track same elgro bots slide come together earnings trick,MRK,0.9511021375656128
2020-04-22,jacobplieth certainly data good based cautiousness exhibited,MRK,0.9560370445251464
2020-04-22,sold west branch capital,MRK,-0.7982439994812012
2020-04-23,watching closely rips change recently taownpntdh,MRK,0.264119416475296
2020-04-23,directional bias report click details,MRK,-0.7779198884963989
2020-04-23,report click sell,MRK,0.2802823483943939
2020-04-23,resubmits supplemental biologics license applications sblas keytruda pembrolizumab dosing schedule,MRK,-0.0174971483647823
2020-04-23,calculated expected return,MRK,-0.2707715034484863
2020-04-23,wondering about risks volatility,MRK,-0.9974579811096193
2020-04-23,stocktwits trending alert recent interest,MRK,0.7507902383804321
2020-04-23,resubmits applications keytruda dosing schedule,MRK,0.0997167900204658
2020-04-23,uptrend moving average convergence divergence macd histogram turned positive view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.960663914680481
2020-04-23,jimcramer what expect earnings,MRK,-0.0501436367630958
2020-04-23,resubmits supplemental biologics license applications regarding updating dosing frequency,MRK,-0.0373013541102409
2020-04-23,refiles application dosing keytruda,MRK,-0.9224933385849
2020-04-23,smart move dosing sbla indications,MRK,0.9736534357070924
2020-04-23,biostocks resubmits sblas keytruda dosing schedule,MRK,-0.0070713944733142
2020-04-23,resubmits supplemental biologics license applications sblas keytruda pembrolizumab dosing,MRK,-0.0300031192600727
2020-04-23,resubmits supplemental biologics license applications sblas keytruda pembrolizumab dosing schedule,MRK,-0.0293449535965919
2020-04-23,refiles application dosing keytruda wronryooym,MRK,-0.0343934744596481
2020-04-23,resubmits supplemental biologics license applications sblas keytruda pembrolizumab dosing schedule,MRK,-0.0174971483647823
2020-04-23,resubmits sblas keytruda dosing schedule,MRK,-0.0495625287294387
2020-04-23,resubmits sblas keytruda dosing schedule,MRK,-0.0268089100718498
2020-04-23,these unprecedented times support people living cancer unwavering check latest oncology update,MRK,0.4269862174987793
2020-04-23,resubmits supplemental biologics license applications keytruda dosing schedule,MRK,-0.0037484616041183
2020-04-23,security national bank grows position,MRK,0.3719930350780487
2020-04-23,holdings raymond james financial services advisors,MRK,-0.5988727807998657
2020-04-23,nicolet advisory services boosts position ofjepwtacv,MRK,0.7409321069717407
2020-04-24,delta expiration maxpain options,MRK,-0.0154787972569465
2020-04-24,lynparza olaparib demonstrated overall survival benefit phase profound trial mutated metastatic castration resistant prostate cancer,MRK,0.7296990156173706
2020-04-24,check latest prostatecancer update hqkwvomfyn,MRK,0.1580007076263427
2020-04-24,guess,MRK,0.0822618901729583
2020-04-24,sigma counselors position,MRK,0.1722451746463775
2020-04-24,close,MRK,-0.3287736475467682
2020-04-24,surinotes invhs esix,MRK,0.0699999034404754
2020-04-24,reports earnings before stockmarket opens wallstreet high estimate mean estimate estimate investingnews stockmarketnews,MRK,0.53397536277771
2020-04-24,strong reliable dividend best dividend screen,MRK,0.9588160514831544
2020-04-24,world america lost soles lesson small world after need come gather happen,MRK,-0.6932399272918701
2020-04-24,invhs esix,MRK,0.0277887098491191
2020-04-24,volume participating,MRK,-1.024946212768555
2020-04-24,options raising write,MRK,0.9704416990280152
2020-04-24,,MRK,-0.0041209571063518
2020-04-24,earnings showing strong fuel sector otherwise reporting companies area reporting along best show,MRK,0.9752061367034912
2020-04-24,monday,MRK,0.1691576689481735
2020-04-24,home gamers powder hold block option help into earnings,MRK,0.8575390577316284
2020-04-24,option chain taken strike little jelly,MRK,-1.0384933948516846
2020-04-24,stop train,MRK,0.3527057468891144
2020-04-24,calls,MRK,0.0606334209442138
2020-04-24,grades show real soon,MRK,0.9663392305374146
2020-04-24,,MRK,0.9167262315750122
2020-04-24,sure positive studies great reads news road lets save lives what moat studies,MRK,0.9940589666366576
2020-04-24,lynparza olaparib demonstrated overall survival benefit phase profound trial zmgefgwapz,MRK,0.8386512994766235
2020-04-24,announces lynparza demonstrated benefit phase profound trial mutated metastatic castration resistant prostate cancer,MRK,0.7356317043304443
2020-04-24,check latest prostatecancer update hqkwvomfyn,MRK,0.0980582609772682
2020-04-24,lynparza demonstrated overall survival benefit phase profound trial mutated metastatic castration resistant prostate cancer,MRK,0.7262245416641235
2020-04-24,resubmits supplementalbiologicslicenseapplications sblas keytruda pembrolizumab dosing schedule osiadussdf,MRK,-0.0248626768589019
2020-04-24,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-04-25,options maxpain chart free options qdrdqchewm,MRK,0.1562585085630417
2020-04-25,options chart free hgyhiwulnm,MRK,0.2098144441843032
2020-04-25,acquired montecito bank trust,MRK,0.4226504266262054
2020-04-25,gemsbot calls,MRK,0.3010084927082062
2020-04-25,calculated expected return,MRK,-0.2450939714908599
2020-04-25,report earnings expected move,MRK,0.545487642288208
2020-04-25,sicart associates sells,MRK,-0.7119756937026978
2020-04-25,moving average crossed above moving average april view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8968733549118042
2020-04-26,long term take short term late monday before closes sell cover calls marketinsurance,MRK,-1.046441674232483
2020-04-26,position reduced financial management professionals ejebqnjpib,MRK,-0.9733633995056152
2020-04-26,wealth management acquires,MRK,0.294665664434433
2020-04-26,merriman wealth management purchases,MRK,0.1932279765605926
2020-04-26,moving average broke above moving average april view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8920172452926636
2020-04-26,gilman hill asset management boosts holdings ogexmtncyh,MRK,0.8351396322250366
2020-04-26,tatrades currently rising support into horizontal resistance currently horizontal resistance,MRK,0.9048360586166382
2020-04-26,scheduled earnings tuesday,MRK,0.036451905965805
2020-04-26,scheduled earnings tuesday,MRK,0.036451905965805
2020-04-26,scheduled earnings tuesday,MRK,0.036451905965805
2020-04-26,currently rising support into horizontal resistance currently horizontal resistance around horizontal support around able break failed keep forward,MRK,-1.0484601259231567
2020-04-27,syinvesting institute systems biology announced collaboration investigate define molecular,MRK,0.0375271402299404
2020-04-27,institute systems biology announced collaboration investigate define molecular mechanisms sars infection covid identify targets medicines vaccines supported barda isbsci,MRK,0.0766695290803909
2020-04-27,earnings preview,MRK,0.0608889311552047
2020-04-27,shiningboy former head vaccines blockbuster gardasil lizclaman show explaining dual action host directed oral drug advantages chairman mayoclinic covid task force principal investigator trail soon video,MRK,0.4636066257953644
2020-04-27,move significant changes taownpntdh,MRK,0.7838858366012573
2020-04-27,whittier trust nevada acquires,MRK,0.2622700035572052
2020-04-27,options flow grid update optionstrading optionsflow stockmarket healthcare,MRK,0.896658182144165
2020-04-27,beats,MRK,0.7625221014022827
2020-04-27,fidelity updates since announce earnings,MRK,0.3389119505882263
2020-04-27,problem reporting want show everyone look great company,MRK,0.9666775465011596
2020-04-27,important remember finasteride propecia proscar increased risk endocrine disorders which covid complications covidsafe,MRK,-0.9203509092330932
2020-04-27,long into earnings,MRK,0.9507330656051636
2020-04-27,reports before open estimize consensus revs compared,MRK,0.1729004681110382
2020-04-27,about regular,MRK,0.3115500211715698
2020-04-27,calls active than puts into outlook thczhcnqep,MRK,0.7641826868057251
2020-04-27,date good long term,MRK,0.9510411024093628
2020-04-27,fuck them numbers,MRK,-1.0056072473526
2020-04-27,girls really glad made earnings volatility optimistic forward glta curtain clear tower what ride,MRK,0.9784973859786988
2020-04-27,reports before open usually early around,MRK,0.2044517546892166
2020-04-27,smart saving lives large moat diverse chain products bayer discontinue chronic cough study already approved,MRK,0.9384335279464722
2020-04-27,around,MRK,0.8439091444015503
2020-04-27,good simple reasoning escalate pasts trying come darken times glta,MRK,0.9577809572219848
2020-04-27,nice reversal green strong,MRK,0.9612358808517456
2020-04-27,looks cake walk soon,MRK,0.279458999633789
2020-04-27,about time dogs,MRK,-0.7122455835342407
2020-04-27,time shine,MRK,0.9658420085906982
2020-04-27,early birds worm,MRK,0.2276539653539657
2020-04-27,interesting health care general strong long respect them glta,MRK,0.9725950956344604
2020-04-27,teams investigate mechanisms covid infection,MRK,-0.8853574991226196
2020-04-27,megtirrell great news clearly best vaccines nice them join party,MRK,0.9639204740524292
2020-04-27,marketcurrents teams investigate mechanisms covid infection,MRK,-0.1133859008550643
2020-04-27,bankthetrade announced presentation interim data cohort keynote phase trial evaluating,MRK,0.8552675247192383
2020-04-27,moving average crossed above moving average april view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8968733549118042
2020-04-27,check latest oncology update,MRK,0.2208184748888015
2020-04-27,teams investigate mechanisms covid infection,MRK,-0.1026457250118255
2020-04-27,teams investigate mechanisms covid infection,MRK,-0.1041088104248046
2020-04-27,announced presentation interim data cohort keynote phase trial evaluating every dosing regimen keytruda anti therapy patients metastatic melanoma,MRK,0.5990880727767944
2020-04-27,check latest oncology update,MRK,0.2052239626646042
2020-04-27,institute systems biology collaborate define molecular mechanisms sars infection identify potential prognostic biomarkers,MRK,0.0532725043594837
2020-04-27,read about research collaboration isbsci consortium research biomed companies identify potential biomarkers,MRK,0.2494548708200454
2020-04-27,institute systems biology collaborate define molecular mechanisms sars infection identify potential prognostic biomarkers,MRK,0.0673811286687851
2020-04-27,jimcramer sciencemag york clinical trial quietly tests heartburn remedy against coronavirus famotidine clinical trial antacid michael callahan massachusetts general hospital stunning article,MRK,0.2656170427799225
2020-04-27,shufro rose boosts stake,MRK,0.4978441298007965
2020-04-27,lynparza demonstrated overall survival benefit phase profound trial mutated metastaticcastrationresistant prostatecancer nqamzqqyxr,MRK,0.8810161352157593
2020-04-27,announce earnings tuesday,MRK,0.0413286499679088
2020-04-27,announce earnings tuesday,MRK,0.0516066774725914
2020-04-27,announce earnings tuesday,MRK,0.0413286499679088
2020-04-27,announce earnings tuesday,MRK,0.0413286499679088
2020-04-27,announce earnings tuesday,MRK,0.0413286499679088
2020-04-27,bought mufg americas holdings corp,MRK,0.5059736967086792
2020-04-28,about latest oncology update hyhmuqvpjm,MRK,0.3296181559562683
2020-04-28,receives approval additional recommended dosage every weeks keytruda,MRK,0.0613141767680645
2020-04-28,earnings intelligence analysis recent earnings identified nyse business focus keytruda tumor keytruda tumors keytruda mutations tumors,MRK,0.121847853064537
2020-04-28,ball rolling fastest approvals recent memory dosing keytruda,MRK,0.7721105813980103
2020-04-28,bigpharmaguy prior dosing every weeks alternate regimen doubles dosage halves number visits wouldn expect drug specific costs change driver lower overall charges administering therapy full course treatment,MRK,0.0794648230075836
2020-04-28,dewdiligence approves dosing keytruda monotherapy iradmuwyxx alternative regimen instead,MRK,-0.0124441236257553
2020-04-28,approves dosing keytruda monotherapy iradmuwyxx alternative regimen instead timely action insofar regimen reduces times patient needs visit clinic during pandemic,MRK,0.2140590697526931
2020-04-28,issues earnings results,MRK,0.0758006945252418
2020-04-28,issues earnings results,MRK,0.1269176453351974
2020-04-28,dosing keytruda,MRK,0.0484611392021179
2020-04-28,keytruda dosing approved announcement resubmission approval only took days,MRK,0.7505679130554199
2020-04-28,dosing keytruda,MRK,0.0484611392021179
2020-04-28,announced approved additional recommended dosage every weeks keytruda across adult indications including monotherapy combination therapy,MRK,0.1202444359660148
2020-04-28,about latest oncology update hyhmuqvpjm,MRK,0.2765686511993408
2020-04-28,lowered revenue expectations about vaccines cancer drugs animal health business face coronavirus related pressures,MRK,-0.8564873933792114
2020-04-28,powerlunch frazier explains company working fight coronavirus pandemic,MRK,0.007692128419876
2020-04-28,gaap beats gaap beats revenue beats,MRK,0.7852960824966431
2020-04-28,seekingalpha frazier results earnings call transcript cinutvrsqn,MRK,0.0293842144310474
2020-04-28,frazier results earnings call transcript cinutvrsqn business stockmarket,MRK,0.0831563621759414
2020-04-28,powerfull sector stay course,MRK,0.9307581186294556
2020-04-28,tuesday despite beating estimates,MRK,-0.7854126691818237
2020-04-28,issues earnings results beats estimates,MRK,0.2575991749763489
2020-04-28,baml objective change guidance cuts doghouse thoughts neutral,MRK,-0.8479396104812622
2020-04-28,announces earnings results beats estimates,MRK,0.4368948638439178
2020-04-28,dawnnewyorker potus realdonaldtrump loudobbs neilmunrodc michellemalkin ingrahamangle anncoulter tuckercarlson seanhannity chuckgrassley senatordurbin senategop senatedems jonvoight jeff scottgottliebmd barackobama berniesanders sundarpichai nygovcuomo drtedros hillaryclinton nikkihaley royalfamily ambjohnbolton narendramodi samanthajpower rajnathsingh ambassadorrice borisjohnson billgates davidaxelrod kingsalman kremlinrussia joebiden ivankatrump speakerpelosi lindseygrahamsc sebgorka chamath jimcramer stevefda jimcramer berniemadoff speaking sell snake remdisivir,MRK,-0.4413254261016845
2020-04-28,governor phil murphy adding frazier commission restarting economy what about push reopen country coronavirus govmurphy njgov,MRK,0.0526979565620422
2020-04-28,frazier explains company working fight coronavirus pandemic aqwuicaksk,MRK,0.0283785462379455
2020-04-28,coming cnbc discuss earnings reverse,MRK,0.1575226783752441
2020-04-28,updates earnings guidance ihkcpnqpxb,MRK,0.0523354671895504
2020-04-28,needs another upwards movement fill less resistance shorts were given fills almost immediately hold tight,MRK,0.7846126556396484
2020-04-28,earnings results live check full financial summary highlights,MRK,0.2510314881801605
2020-04-28,bythenumbers check highlights earnings report xbyeopsutd,MRK,0.0169075429439544
2020-04-28,earnings call preliminary transcript pharmaceuticals earnings,MRK,0.0170922428369522
2020-04-28,tumbles after component forecasts impact coronavirus pandemic fiscal quarters earnings,MRK,-0.8040125370025635
2020-04-28,tumbles after component forecasts impact coronavirus pandemic fiscal quarters tdliesbkjn earnings,MRK,-0.8040125370025635
2020-04-28,after sales warning,MRK,-0.0504637993872165
2020-04-28,starts feel covid effects realjacobbell,MRK,-0.0926283150911331
2020-04-28,update investorplace mission control pharmaceutical struggling drug sales drop,MRK,-1.0693968534469604
2020-04-28,reaping dividends helps,MRK,0.9715205430984496
2020-04-28,good good later earnings pidvlbbopl,MRK,0.7747069597244263
2020-04-28,think zacks about ready upgrade revenue report,MRK,0.984628438949585
2020-04-28,pharma sales overall sales billion profit billion what think people better life priceless,MRK,0.8733711242675781
2020-04-28,updates earnings guidance,MRK,0.0523354671895504
2020-04-28,updates earnings guidance,MRK,0.0714775025844574
2020-04-28,earnings move expected move,MRK,-0.0363813936710357
2020-04-28,michael levesque anticipated sales rebound addition strong underlying demand products lead sales rebound pandemic eventually ebbs,MRK,0.9831746816635132
2020-04-28,beleave upgrades come,MRK,0.9630234241485596
2020-04-28,moody senior vice president michael levesque weighs earnings impact coronavirus pharma,MRK,-0.1073479205369949
2020-04-28,guard golden eggs,MRK,0.9875096082687378
2020-04-28,real good,MRK,-0.3858712613582611
2020-04-28,watch quick scalp short,MRK,-0.9103049039840698
2020-04-28,weak hung vwap flat bottom breakdown need pull help,MRK,-1.0602470636367798
2020-04-28,beats estimate sales beat estimate earnings stockmarket ycctcszzud,MRK,0.8840433359146118
2020-04-28,results earnings call presentation economy,MRK,0.084984466433525
2020-04-28,solid company great revenue saving life helping peoples animals health better bless,MRK,0.996994972229004
2020-04-28,jacobplieth covid impact,MRK,0.0407418385148048
2020-04-28,semodough baml wouldn surprised modest pressure given negative implications only does,MRK,-1.080538630485535
2020-04-28,management prudent upstanding indicate possible head winds prudent,MRK,0.9634273052215576
2020-04-28,earnings revenues estimates,MRK,0.8624844551086426
2020-04-28,heads approaching high hold mvpnjxkclm,MRK,0.9136359691619872
2020-04-28,premarket sees billion full sales coronavirus pandemic earnings,MRK,-0.9205117225646972
2020-04-28,beats beats revenue,MRK,0.4970614016056061
2020-04-28,earnings call david risinger morgan stanley analyst jokingly asked official comment using disinfectant light potential coronavirus medicines,MRK,0.120367407798767
2020-04-28,beats beats revs lowers guidance below consensus revs below consensus,MRK,-0.8346282243728638
2020-04-28,profit beats coronavirus uncertainty weighs forecast reuters,MRK,-0.2145239561796188
2020-04-28,lowering guidance only considering impacts while keytruda indications money made lung cancer speculate impact longer cancer diagnosis delayed survival rate declines virus,MRK,-0.8881803750991821
2020-04-28,beats estimate sales beat estimate sees,MRK,0.5240551233291626
2020-04-28,baml wouldn surprised modest pressure given negative implications only does revision raise question whether amendments outlook pandemic continues unfold,MRK,-1.0787194967269895
2020-04-28,first clinical outcomes evaluating dosing schedule keytruda pembrolizumab presented,MRK,0.0876782983541488
2020-04-28,beats estimate sales beat estimate sees sales,MRK,0.4748320281505584
2020-04-28,bythenumbers check highlights earnings report xbyeopsutd,MRK,0.0554186813533306
2020-04-28,beats beats revenue nyse gaap beats gaap beats revenue beats,MRK,0.8521498441696167
2020-04-28,advanced discussions multiple groups focusing different viral vaccine platforms says details come future,MRK,0.0841996893286705
2020-04-28,keytruda sales guidance lowered covid impact,MRK,0.0392622873187065
2020-04-28,livesquawk earnings revenue lowers revenue range,MRK,-0.0895173847675323
2020-04-28,profit rises cuts forecast covid uncertainty,MRK,0.571195125579834
2020-04-28,better than expected earnings warns lower sales,MRK,0.2277748584747314
2020-04-28,reports beats strong numbers lowers guidance premarket,MRK,0.9508844614028932
2020-04-28,join learn about earnings,MRK,0.2151167243719101
2020-04-28,join learn about earnings,MRK,0.2491958886384964
2020-04-28,covid impact,MRK,0.0214415341615676
2020-04-28,likely patients younger disease mostly chronic unfortunately lung melanoma patients succumb disease eventually hand always drug inflation,MRK,-0.9366044998168944
2020-04-28,date announced little drug development seems changing,MRK,-0.2012317776679992
2020-04-28,cuts full guidance covid pandemic takes toll keytruda vaccines,MRK,-0.7415148019790649
2020-04-28,beats consensus,MRK,0.3998441994190216
2020-04-28,advanced discussions multiple groups focusing different viral vaccine platforms details those collaborations announced necessary arrangements finalize says,MRK,0.0407448858022689
2020-04-28,calculated expected return,MRK,0.8288919925689697
2020-04-28,regarding virus says started broad drug development program builds experience vaccines antiviral medications,MRK,0.001760434359312
2020-04-28,biostocks lowers view,MRK,-0.9645156860351562
2020-04-28,lowering revenue estimate between because impact coronavirus,MRK,-0.9948302507400512
2020-04-28,filing form,MRK,0.0169025622308254
2020-04-28,reports sales increase same period keytruda sales,MRK,0.9559894800186156
2020-04-28,lowers view,MRK,-0.961174249649048
2020-04-28,marketcurrents beats beats revenue rcpcmzpwpj,MRK,0.5400816202163696
2020-04-28,beats sales beat sees,MRK,0.5002585649490356
2020-04-28,company filing form wrgofurwoi,MRK,-0.0701673179864883
2020-04-28,tops revenues beat lowers revenue guidance below consensus,MRK,0.2054691910743713
2020-04-28,beats sales beat sees sales,MRK,0.4322774112224579
2020-04-28,accurate estimate beating analysts wall street consensus,MRK,0.7897094488143921
2020-04-28,beats estimize consensus estimize revenue consensus reports earnings revs,MRK,0.7466635704040527
2020-04-28,reports earnings revs,MRK,0.1688257455825805
2020-04-28,semodough impact covid company lowers full gaap range between lowers,MRK,-0.0793291181325912
2020-04-28,impact covid company lowers full gaap range between lowers full gaap range between including negative impact foreign exchange approximately,MRK,-1.0476744174957275
2020-04-28,shocked shouldn,MRK,-1.0374349355697632
2020-04-28,earnings revenue lowers revenue range,MRK,-0.3430846631526947
2020-04-28,keytruda billion,MRK,0.1440730541944503
2020-04-28,earnings results live check full financial summary highlights,MRK,0.2128342986106872
2020-04-28,scheduled announce earnings results tuesday april before open consensus estimate consensus revenue estimate earnings stockmarket,MRK,0.6247225999832153
2020-04-28,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-04-28,know wallstreet,MRK,0.1186129599809646
2020-04-28,know book value dscbstdrpg,MRK,0.6823546886444092
2020-04-28,unicorn rating,MRK,0.3191361427307129
2020-04-28,options maxpain chart free options,MRK,0.1562585085630417
2020-04-29,strong usmarkets mega healthcare technical analysis mgyatpfgxq,MRK,0.951967716217041
2020-04-29,land dime,MRK,0.9450087547302246
2020-04-29,received letter president trump signed nice frame,MRK,0.9435479640960692
2020-04-29,earnings results beats expectations zjztlmiwka,MRK,0.3329212367534637
2020-04-29,issues earnings guidance,MRK,0.0417633987963199
2020-04-29,target lowered barclays,MRK,-0.9682822227478028
2020-04-29,bots almost make look real,MRK,0.7026196718215942
2020-04-29,hump afterall kick,MRK,0.9533261060714722
2020-04-29,come folks lets make special,MRK,0.9908801317214966
2020-04-29,stockmarket robinhoodapp stillwatchlist startsmall,MRK,0.1000927612185478
2020-04-29,manual exit closing position opened gain,MRK,0.9370406866073608
2020-04-29,lowered,MRK,-0.9473607540130616
2020-04-29,almost close play,MRK,0.5509557723999023
2020-04-29,analysts focus fundamentals keytruda strength guidance,MRK,-0.7559970617294312
2020-04-29,gains after profit sales beat outlook downbeat however working oxford university which world first effective vaccine,MRK,0.9347823858261108
2020-04-29,long looking close days,MRK,0.0709080621600151
2020-04-29,hook line,MRK,0.2991538941860199
2020-04-29,volume gild mill,MRK,0.1173671633005142
2020-04-29,looks gild headline stooled little fire come back play settles,MRK,0.1109183579683303
2020-04-29,upgrades place seat belt,MRK,0.7913651466369629
2020-04-29,raised barclays,MRK,0.900000810623169
2020-04-29,nice upward targets kitty,MRK,0.9709912538528442
2020-04-29,strong busy,MRK,0.9696918725967408
2020-04-29,approves keytruda pembrolizumab additional recommended dose every weeks approved adult indications,MRK,0.901503324508667
2020-04-29,turn green,MRK,-0.0308307893574237
2020-04-29,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news ntmqyuuuxx,MRK,0.9489938020706176
2020-04-29,briefingcom receives approval additional recommended dosage every weeks keytruda,MRK,0.1145076900720596
2020-04-29,finmktsenglish beat bottom lines sales gaap income,MRK,0.8639264106750488
2020-04-29,pain maturity maxpain options,MRK,-0.111636146903038
2020-04-29,beat bottom lines sales gaap income lowered full guidance covid flagship immuno oncology drug keytruda sales dividend,MRK,0.90216064453125
2020-04-29,maybe takes pause after hurts business given heavy doctor admin products,MRK,-1.083142638206482
2020-04-29,recommendation hold rating,MRK,-0.2410321235656738
2020-04-29,high dividend rating which makes good candidate dividend,MRK,0.9550071954727172
2020-05-03,bneiluj aaveaave zmanian stanikulechov dystopialabs ethereum cosmos polkadotnetwork tezos nearprotocol mean crypto afterall free money volatility ploys simple washing excercises only thing gullible holders lose everytime kurtosis skewness distribution returns look latest auctions plutocracy wins,MRK,0.9669421911239624
2020-05-03,acquired chartwell partners,MRK,0.4082000851631164
2020-05-03,janney capital management raises position,MRK,0.6960735321044922
2020-05-03,narwhal capital management grows holdings,MRK,0.714261531829834
2020-05-03,banque pictet million holdings bolxtjoonf,MRK,0.147798091173172
2020-05-03,illinois municipal retirement fund million stake,MRK,0.203742429614067
2020-05-03,targitting,MRK,-0.0156897865235805
2020-05-03,personal solutions million holdings skplezpfvz,MRK,0.1008530482649803
2020-05-03,bessemer securities boosts holdings,MRK,0.6741716861724854
2020-05-03,dakota wealth management reduces position,MRK,-0.6967477798461914
2020-05-03,estimated earnings current,MRK,0.4583513140678406
2020-05-03,tickeron downtrend moving average convergence divergence macd histogram turned negative view odds othe,MRK,-1.0884195566177368
2020-05-03,unicorn rating,MRK,0.3308245837688446
2020-05-03,downtrend moving average convergence divergence macd histogram turned negative view odds indicators stockmarket technicalanalysis money daytrading news,MRK,-1.0829312801361084
2020-05-03,directional bias report click details,MRK,-0.7779198884963989
2020-05-03,report click sell,MRK,0.2802823483943939
2020-05-03,earnings estimate issued leerink,MRK,0.0384973473846912
2020-05-03,earnings estimate issued leerink,MRK,0.0384973473846912
2020-05-03,earnings estimate issued leerink,MRK,0.0522832982242107
2020-05-04,delta expiration maxpain options,MRK,-0.018617033958435
2020-05-04,rating reiterated credit suisse group ratingsnetwork,MRK,0.8651648759841919
2020-05-04,signals large biopharma acquirers picking sanofi highlighting gene therapy interest,MRK,0.7829583883285522
2020-05-04,stockonomist dddd pharma good intro video what microbiome unicorn,MRK,0.9645845890045166
2020-05-04,reiterated bycredit suisse group,MRK,0.90359365940094
2020-05-04,rating reiterated credit suisse group,MRK,0.2689386308193207
2020-05-04,rating reiterated credit suisse group,MRK,0.2689386308193207
2020-05-04,rating reiterated credit suisse group jyzmktisfw,MRK,0.4059645235538482
2020-05-04,downtrend moving average convergence divergence macd histogram turned negative view odds indicators srmxqtfuoo stockmarket technicalanalysis money daytrading news,MRK,-1.0829312801361084
2020-05-04,dddd pharma good intro video what microbiome unicorn signed vaccine licence deal keytruda phase cancer trial alongside potential treatment clinical trials,MRK,0.9798202514648438
2020-05-04,estimates reduced cantor fitzgerald jjimwgpytz,MRK,-0.9876612424850464
2020-05-05,insider filing chief commercial officer frank clyburn,MRK,0.0467276871204376
2020-05-05,insider filing general counsel jennifer zachary,MRK,0.0501331500709056
2020-05-05,insider filing fince global controller rita karachun,MRK,0.0430259928107261
2020-05-05,insider filing chairman president kenneth frazier,MRK,0.0565238893032074
2020-05-05,small action calls think drug plays want,MRK,-0.2122230231761932
2020-05-05,insider filing pres sanat chattopadhyay,MRK,0.0461426600813865
2020-05-05,options maxpain chart free options,MRK,0.1562585085630417
2020-05-05,company filing form,MRK,-0.0484154559671878
2020-05-05,power close,MRK,0.035417653620243
2020-05-05,filling upward,MRK,0.0806554481387138
2020-05-05,commits additional million covid relief efforts help disparately impacted patients communities mfgvudijuh,MRK,0.8060410022735596
2020-05-05,apears sector looks beach,MRK,0.2315754741430282
2020-05-05,alarmingly vaccine appeared increase rate infection individuals prior immunity against adenovirus vector used vaccine antibody dependent enhancement vaccines treatment implications,MRK,0.8625985383987427
2020-05-05,headed,MRK,0.5152170658111572
2020-05-05,surprising data point disclosed third keytruda sales come covered entities evidence program unexpectedly large pharma discounts likely,MRK,0.197715938091278
2020-05-05,commits additional million covid relief efforts help disparately impacted patients oaqrsdfbhj,MRK,0.8054190874099731
2020-05-05,commits additional million covid relief efforts help disparately impacted patients communities,MRK,0.8580276966094971
2020-05-05,earnings estimate issued cantor fitzgerald,MRK,0.0666541010141372
2020-05-05,earnings estimate issued cantor fitzgerald,MRK,0.0666541010141372
2020-05-05,brokers issue forecasts earnings,MRK,-0.2447824329137802
2020-05-05,turn green,MRK,-0.0178564935922622
2020-05-06,insider filing fince global controller rita karachun,MRK,0.0430259928107261
2020-05-06,showing best dividend selection,MRK,0.9697375297546388
2020-05-06,insider filing chief ethics officer michael fleming,MRK,0.0499591752886772
2020-05-06,company filing form feyiqvfume,MRK,-0.0484154559671878
2020-05-06,learn about latest news infectiousdiseases,MRK,0.3801568150520324
2020-05-06,hump turn corner,MRK,0.3183093667030334
2020-05-06,machine enjoy gift,MRK,0.9822213649749756
2020-05-06,results phase trial evaluating efficacy safety recarbrio imipenem cilastatin relebactam versus piperacillin tazobactam adult patients habp vabp available,MRK,0.2797662317752838
2020-05-06,easy,MRK,0.96509051322937
2020-05-06,announces results restore phase clinical trial evaluating recarbrio treatment fryoimybyb,MRK,-0.0413974523544311
2020-05-06,insider filing chief marketing officer michael nally,MRK,0.0559068545699119
2020-05-06,insider filing pres roger perlmutter kqfoavkxoi,MRK,0.0459611564874649
2020-05-06,announces results phase trial evaluating recarbrio versus piperacillin tazobactam adult patients habp vabp available,MRK,0.2115799486637115
2020-05-06,major quote changes,MRK,0.1548679620027542
2020-05-06,results phase trial evaluating efficacy safety recarbrio imipenem cilastatin qjcdrvfbra,MRK,0.2349910289049148
2020-05-06,results phase trial evaluating efficacy safety recarbrio imipenem cilastatin relebactam versus piperacillin tazobactam adult patients habp vabp available,MRK,0.2914058864116668
2020-05-06,learn about latest news infectiousdiseases,MRK,0.3638583421707153
2020-05-06,aroon indicator drops into downtrend view odds indicators stockmarket technicalanalysis money daytrading news dollbhcfck,MRK,-1.076823592185974
2020-05-06,earnings leerink forecasts,MRK,0.3363118171691894
2020-05-06,earnings leerink forecasts znytmidqbr,MRK,0.3363118171691894
2020-05-06,earnings leerink forecasts,MRK,0.3363118171691894
2020-05-06,research analysts expectations earnings,MRK,0.0855654627084732
2020-05-06,research analysts expectations earnings,MRK,0.0855654627084732
2020-05-06,research analysts expectations earnings,MRK,0.0855654627084732
2020-05-06,insider filing strat comm policy julie gerberding jkwrzneiuf,MRK,0.0452404730021953
2020-05-06,insider filing chief ethics officer michael fleming,MRK,0.0499591752886772
2020-05-06,insider filing pres animal heallth richard deluca,MRK,0.0445935651659965
2020-05-06,insider filing chief officer steven mizell nwmpxuhoan,MRK,0.048746895045042
2020-05-06,domain therapeutics receives development milestone payment kgaa darmstadt germany adenosine receptor antagonist strategic assets immuno oncology pipeline,MRK,0.1947578340768814
2020-05-06,insider filing global svcs robert davis,MRK,0.0447906330227851
2020-05-07,insider filing director leslie brun,MRK,0.0547561459243297
2020-05-07,director wendell weeks sells,MRK,-0.7674075365066528
2020-05-07,wendell weeks sells,MRK,-0.7210276126861572
2020-05-07,director wendell weeks sells,MRK,-0.4419125914573669
2020-05-07,leslie brun dumps,MRK,-0.9418410062789916
2020-05-07,company filing form nfzjtgbzyx,MRK,-0.0484154559671878
2020-05-07,insider selling,MRK,-1.0529016256332395
2020-05-07,stockmarket reported sales sales were grew gizpwdxiph,MRK,0.9618664979934692
2020-05-07,present securities health care conference,MRK,0.0048141553997993
2020-05-07,present data broad oncology portfolio pipeline virtual scientific program,MRK,0.1620094627141952
2020-05-07,looks options time showing lift into,MRK,0.5747636556625366
2020-05-07,fear factor causing mode,MRK,-1.060494065284729
2020-05-07,good eggs great hand cards showing near term,MRK,0.969574213027954
2020-05-07,struggling lately feel missing something,MRK,-1.0615965127944946
2020-05-07,present securities health care conference,MRK,0.0048141553997993
2020-05-07,plenary session feature phase data keytruda pembrolizumab dmmr colorectal cancer long term data keytruda than tumor types including triple negative breast cancer classical hodgkin lymphoma small cell lung cancer,MRK,0.0779140889644622
2020-05-07,present data broad oncology portfolio pipeline virtual scientific program,MRK,0.1620094627141952
2020-05-07,downtrend moving average convergence divergence macd histogram turned negative view odds indicators stockmarket technicalanalysis money daytrading news,MRK,-1.0829312801361084
2020-05-07,reveal findings oncology program cancer oncology,MRK,0.1190833449363708
2020-05-07,proud present securities health care conference,MRK,0.93279767036438
2020-05-07,sharing latest oncology data studies asco sure conversation,MRK,0.3395535051822662
2020-05-07,chart starting weaken recrosses bearish lower rolling opening,MRK,-1.0854798555374146
2020-05-07,insider filing general counsel jennifer zachary pmctlxtije,MRK,0.0501331500709056
2020-05-07,insider filing chief marketing officer michael nally vyeallulav,MRK,0.0559068545699119
2020-05-07,breaks back below moving average sentiment neutral,MRK,-1.0040843486785889
2020-05-07,insider filing chief commercial officer frank clyburn,MRK,0.0467276871204376
2020-05-08,astrazeneca announce approved lynparza epithelial ovarian fallopian tube,MRK,0.1855059713125229
2020-05-08,lynparza olaparib approved first line maintenance treatment bevacizumab positive advanced,MRK,0.855420708656311
2020-05-08,lynparza olaparib approved first line maintenance treatment bevacizumab positive advanced ovarian cancer,MRK,0.7319437265396118
2020-05-08,lynparza olaparib approved first line maintenance treatment bevacizumab positive jhnhrjnkit,MRK,0.8412274122238159
2020-05-08,learn about recent update ovariancancer gfqemlcvcg,MRK,0.1510354578495025
2020-05-08,lynparza approved first line maintenance treatment bevacizumab positive advanced ovarian cancer,MRK,0.6928979158401489
2020-05-08,company pick stockchase finance stockmarket stockpicks,MRK,0.9871031045913696
2020-05-08,company company finance stockmarket stockpicks,MRK,0.9131320714950562
2020-05-08,cfra adds portfolio strong rating,MRK,0.960007905960083
2020-05-08,credit suisse group reaffirms rating,MRK,0.9086083173751832
2020-05-08,director wendell weeks sells qauwuwfkvr,MRK,-0.4419125914573669
2020-05-08,director wendell weeks sells,MRK,-0.4419125914573669
2020-05-08,announces virtual meeting,MRK,0.0249849148094654
2020-05-08,announces virtual meeting,MRK,0.0249849148094654
2020-05-08,meeting held virtually learn,MRK,0.008015651255846
2020-05-08,meeting held virtually learn,MRK,0.0357306078076362
2020-05-08,downtrend moving average convergence divergence macd histogram turned negative view odds indicators stockmarket technicalanalysis money daytrading news,MRK,-1.0829312801361084
2020-05-08,present securities health care conference ulebgoxglw,MRK,0.0048141553997993
2020-05-08,insider filing director wendell weeks hktkanyqre,MRK,0.0497046485543251
2020-05-09,earnings expected quarter,MRK,0.518466591835022
2020-05-09,missing boat,MRK,-1.045998215675354
2020-05-09,upcoming event securities health care conference options expiring cover event implied move,MRK,0.2355734854936599
2020-05-09,aroon indicator drops into downtrend view odds indicators stockmarket technicalanalysis money daytrading news amcjqksetz,MRK,-1.0772112607955933
2020-05-09,wendell weeks sells,MRK,-0.7210276126861572
2020-05-09,director sells,MRK,-0.8114035129547119
2020-05-09,technical alerts narrow range handle,MRK,-0.0668615028262138
2020-05-09,kgaa kgaa general held form virtual accordance german mitigate consequences covid pandemic physical presence authorised,MRK,-0.0844051167368888
2020-05-09,learn about recent update ovariancancer gfqemlcvcg,MRK,0.1772086322307586
2020-05-09,futhan nafamostat mesilate drug treating acute pancreatitis being studied japan avigan favipar,MRK,-0.026069987565279
2020-05-28,announces keytruda monotherapy significantly reduced risk disease progression death,MRK,-0.0306372940540313
2020-05-28,jacobplieth adverse events conclusions keynote thierry wxigtnpysi,MRK,-0.1743035465478897
2020-05-28,keytruda pembrolizumab plus lenvima lenvatinib combination demonstrated clinically meaningful tumor,MRK,0.4673613011837005
2020-05-28,through collaboration eisaius exploring options patients living kidneycancer those livercancer learn about data,MRK,0.6029987335205078
2020-05-28,keytruda plus lenvima combination demonstrated clinically meaningful tumor response rates unresectable hepatocellular carcino,MRK,0.5138977766036987
2020-05-28,keytruda superior standard care chemotherapy patients colorectal cancer,MRK,0.8128596544265747
2020-05-28,optimus maximus shorted opened corp chance loss hold stats,MRK,0.8733588457107544
2020-05-28,keytruda line treatment doubles colorectal cancer patients certain mutation npdbdjaqeo,MRK,0.5843216180801392
2020-05-28,keytruda pembrolizumab superior standard care chemotherapy patients colorectal cancer,MRK,0.9228299856185912
2020-05-28,keytruda pembrolizumab superior standard care chemotherapy patients colorectal,MRK,0.9164299964904784
2020-05-28,about first curves cross psuedoprogression hardly events around median long progression free tail cure,MRK,0.3530265092849731
2020-05-28,adverse events conclusions keynote thierry wxigtnpysi,MRK,-0.1110510155558586
2020-05-28,keytruda pembrolizumab superior standard care chemotherapy patients colorectal cancer related tickers,MRK,0.9134255647659302
2020-05-28,unwavering commitment cancer community bring options patients check latest oncology update cmqwetogke,MRK,0.7021031379699707
2020-05-28,throughs ring virus,MRK,0.2773396968841553
2020-05-28,rising declining volume pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-0.8760040998458862
2020-05-28,themis bioscience innovative young biotech company promising platform technology acquired pharma comp,MRK,0.976455807685852
2020-05-28,earnings summary,MRK,0.0244509167969226
2020-05-28,upping stop entry zagwxhliwp,MRK,-1.0070875883102417
2020-05-28,dividend june,MRK,-0.0587130784988403
2020-05-28,bought,MRK,0.9381684064865112
2020-05-28,radar story,MRK,-0.0283560007810592
2020-05-28,deal making spree drug giant partnering local startup develop vaccine distributing patch,MRK,0.0428735986351966
2020-05-28,watchlist late,MRK,-0.0160137191414833
2020-05-28,bouncing back,MRK,0.970456600189209
2020-05-28,added,MRK,0.8559621572494507
2020-05-28,optimus maximus shorted opened corp chance loss hold stats,MRK,0.8763312101364136
2020-05-28,surprised muted response news playing catch,MRK,-0.9089800119400024
2020-05-28,line positive,MRK,0.9333423376083374
2020-05-28,preferential access themis potential covid vaccine coronavirus,MRK,0.020803727209568
2020-05-28,moving average moved above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.910811185836792
2020-05-28,merckco bidaskscore lowered sold,MRK,-0.9709243774414062
2020-05-28,sentiment total scores positive negative sentiment,MRK,-0.050377283245325
2020-05-28,teslacharts eisen misrepresent best favorite recent moment attacked vaccine development time line being conservative classy response,MRK,0.9312077760696412
2020-05-29,sickeconomics rnaianalyst kenneth frazier come into race clear steady objectives shot,MRK,0.2883286774158478
2020-05-29,love hear thoughts either though,MRK,0.0024266988039016
2020-05-29,rnaianalyst kenneth frazier come into race clear steady objectives shot multiple studies proven tech platform someone adult room,MRK,0.6910780668258667
2020-05-29,guys,MRK,-0.0048232786357402
2020-05-29,cadeinvests bought,MRK,0.957332730293274
2020-05-29,files form submission matters vote security holders form,MRK,0.0407510362565517
2020-05-29,asco keytruda standard biomarker driven cancer lwydxpqogl oncology,MRK,0.078214131295681
2020-05-29,weak technical analysis score score breakdown categories candle score excellent moving average score poor momentum score weak stockmarket,MRK,-0.990619659423828
2020-05-29,keytruda pembrolizumab plus lenvima lenvatinib combination demonstrated clinically meaningful tumor response rates unresectable hepatocellularcarcinoma advanced renalcellcarcinoma,MRK,0.8517041206359863
2020-05-29,keytruda pembrolizumab superior standard care chemotherapy patients msih colorectalcancer,MRK,0.9103809595108032
2020-05-29,announced keytruda plus lenvima combination demonstrated clinically meaningful tumor response rates unresectable hepatocellular carcinoma advanced renal cell carcinoma related tickers,MRK,0.814635157585144
2020-05-29,time take flight,MRK,0.0872434675693512
2020-05-29,openoutcrier keytruda lenvima combo shows benefit liver kidney cancers,MRK,0.8921911716461182
2020-05-29,keytruda lenvima combo shows benefit liver kidney cancers,MRK,0.8507498502731323
2020-05-29,moving average broke above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8921972513198853
2020-05-29,keytruda lenvima combo shows benefit liver kidney cancers,MRK,0.7588087320327759
2020-05-29,keytruda lenvima combo shows benefit liver kidney cancers,MRK,0.7588087320327759
2020-05-29,options flow grid update optionstrading optionsflow stockmarket healthcare,MRK,0.8550266027450562
2020-05-29,update preferential access themis potential covid vaccine coronavirus,MRK,0.0368397161364555
2020-05-29,semodough mizhou keynote significance asco late breaker relevance keytruda reduced risk disease,MRK,0.8314826488494873
2020-05-29,long vaccine game buys into patch delivery tech pandemic potential,MRK,0.950193166732788
2020-05-29,briefingcom announces keytruda monotherapy significantly reduced risk disease progression death,MRK,-0.3566142618656158
2020-05-29,mizhou keynote significance asco late breaker relevance keytruda reduced risk disease progression death versus standard care keytruda months months responses were durable years,MRK,0.8842352628707886
2020-05-30,major changes,MRK,0.306290328502655
2020-05-30,receives consensus recommendation analysts crdgdqolhb,MRK,0.8555986881256104
2020-05-30,receives consensus recommendation analysts bbjzapvcrr,MRK,0.8555986881256104
2020-05-30,short interest only,MRK,0.5241380929946899
2020-05-30,ahead biotech asco menlo decisions ipos spotlight,MRK,0.0025481395423412
2020-05-30,clear risk mghxtjkzdb,MRK,-1.0082653760910034
2020-05-30,moving average crossed above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8971023559570312
2020-05-30,george floyd family deserve justice families people killed vioxx drugs justiceforgeorgefloyd minneapolisuprising minneapolisprotests riots ahmaudarbery arrestkenfrazier arrestraygilmartin,MRK,-0.3318096697330475
2020-05-30,form submission matters vote security holders meeting held voted matters fort,MRK,0.0850650742650032
2020-05-30,puts option volume volume,MRK,0.8864892721176147
2020-05-30,markhillman hedgefund continues invest,MRK,0.18728868663311
2020-05-31,pain maturity maxpain options,MRK,-0.1083481311798095
2020-05-31,good news keytruda excellent data patients high mutation burden oncology,MRK,0.9824929237365724
2020-05-31,keytruda phase study shows double progression time months untreated colon cancer dmmr mutations both hinder repair standard chemotherapy regiment another keytruda statnews asco seconds newsletter,MRK,0.9382305145263672
2020-05-31,stake lessened partners,MRK,-0.5495576858520508
2020-05-31,directional bias report click details,MRK,-0.7779198884963989
2020-05-31,report click sell,MRK,0.2802823483943939
2020-05-31,pain maturity maxpain options,MRK,-0.0233973562717437
2020-05-31,unveils virus vaccine candidates while warning timeline,MRK,-0.0493859983980655
2020-05-31,worth taking position bottoms change recently,MRK,0.9540355205535888
2020-05-31,aaabiotech think bright raised concern barda before demoted drbright,MRK,0.5126692056655884
2020-05-31,think bright raised concern barda before demoted drbright,MRK,-0.1405027210712433
2020-05-31,moving average moved above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.910811185836792
2020-05-31,chart watch,MRK,0.1742499470710754
2020-05-31,pain maturity maxpain options,MRK,-0.1083481311798095
2020-05-31,thepupofwallst looking catch,MRK,0.3224327862262726
2020-06-01,what need black daughter after killing george floyd,MRK,-0.7712883949279785
2020-06-01,carlquintanilla quote frazier cnbc rings loud,MRK,-0.0367160886526107
2020-06-01,treycottone profitable company growing industry checks boxes dividend yield growth rate,MRK,0.9680473804473876
2020-06-01,below volume pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-0.899850606918335
2020-06-01,optimus maximus closed covered previously shorted loss corp stats,MRK,-1.077039122581482
2020-06-01,gregmannarino finally ready,MRK,0.672209620475769
2020-06-01,profitable company growing industry checks boxes dividend yield growth rate beta great long term appears making than enough money handle debts oeepbufkxu,MRK,0.9729900360107422
2020-06-01,treycottone what take,MRK,-0.0866816565394401
2020-06-01,monday,MRK,0.8468433618545532
2020-06-01,speaks racial injustice blacklivesmatter businessleaders corporateamerica georgefloyd murder policebrutality protests racism xrjllefilp,MRK,-0.1402791142463684
2020-06-01,matthewherper chrisheery outstanding leader live powerful,MRK,0.9371159076690674
2020-06-01,clock rock,MRK,0.9881720542907716
2020-06-01,something cnbc,MRK,0.076121911406517
2020-06-01,change recently taownpntdh,MRK,0.0353864468634128
2020-06-01,growing moat larger time glta,MRK,0.8977420330047607
2020-06-01,sold,MRK,-1.0120805501937866
2020-06-01,weeks helenbranswell interview julie gerberding chief patient officer ashishkjha both about really hope olhumxvvqt,MRK,-0.0240432955324649
2020-06-01,quote frazier cnbc rings loud,MRK,-0.0705324485898017
2020-06-01,greenwillowfan millions before jnjnews before before gileadsciences medicalvape story,MRK,-0.0069610550999641
2020-06-01,cnbcpro important thought provoking interview frazier about georgefloyd racism what american businesses well worth minutes life,MRK,0.4098437130451202
2020-06-01,love frazier,MRK,0.8908809423446655
2020-06-01,matthewherper,MRK,0.0783307179808616
2020-06-01,person speak about situation substance convo matters,MRK,0.2933953106403351
2020-06-01,kenneth frazier george floyd sypnkpizni,MRK,0.0447485148906707
2020-06-01,frazier continues serve gold standard leadership business leadership probably serve well arenas,MRK,0.9556347131729126
2020-06-01,long,MRK,0.9168388843536376
2020-06-01,recent pancreaticcancer update,MRK,-0.0360758975148201
2020-06-01,best behind everyday cnbc nobody gives shit about mentoring these days want dollahs robots proud represent,MRK,0.9973978996276855
2020-06-01,sounded endorsed busing joesquawk,MRK,0.2645855844020843
2020-06-01,astrazeneca confirm lynparza received positive opinion chmp first line maintenance,MRK,0.9284363985061646
2020-06-01,mellodyhobson kennethfrazier africanamerican mega pharma company valuation billion qualified joebiden needs give spot administration,MRK,0.0377960801124572
2020-06-01,kennethfrazier africanamerican mega pharma company valuation billion qualified joebiden needs give spot administration,MRK,-0.2121472805738449
2020-06-01,matthewherper,MRK,0.0402204692363739
2020-06-01,carlquintanilla cnbc impressive informative inspirational full practical suggestions kudos blessed leader,MRK,0.942297339439392
2020-06-01,renohemonc slide overman discussant study,MRK,-0.2900506258010864
2020-06-01,interestingly michael overman discussant doesn think assume benefit ebfxwytryn,MRK,0.8138480186462402
2020-06-01,michael overman discussant study comments those curves crossing,MRK,-0.0559757985174655
2020-06-01,frazier andrewrsorkin squawkstreet beckyquick kenfrazier makeamericamoreequitable,MRK,0.6447993516921997
2020-06-01,lynparza olaparib receives positive opinion chmp first line maintenance treatment patients germline brca mutated metastatic pancreatic cancer,MRK,0.923200249671936
2020-06-01,,MRK,0.0238915309309959
2020-06-01,lynparza olaparib receives positive opinion chmp first line maintenance treatment patients,MRK,0.9254820346832277
2020-06-01,lynparza receives positive opinion chmp first line maintenance treatment patients germline brca mutated,MRK,0.9267597198486328
2020-06-01,recent pancreaticcancer update,MRK,-0.0346789211034774
2020-06-01,bill cosby thought crimes were buried past figured never receive justice wrong same fate awaits murderers criminals liars cowards justiceforgeorgefloyd usaonfire minneapolisriot minneapolisuprising,MRK,-0.6452780961990356
2020-06-01,looking entry change recently,MRK,0.899438738822937
2020-06-01,moving average moved above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.910811185836792
2020-06-01,brokerages expect,MRK,0.0747684761881828
2020-06-01,company nyse impulse wave visit detailed multi time frame elliottwave analysis rpqfxjeync,MRK,-0.066454216837883
2020-06-01,broad turning green green reversal coming change recently,MRK,0.617568850517273
2020-06-01,realdonaldtrump emilahp designate terrorist organization justiceforahmaudarbery justiceforvioxxvictims justiceforgeorgesfloyd arrestkenfrazier,MRK,-0.8360581398010254
2020-06-02,insider filing director leslie brun,MRK,0.0547561459243297
2020-06-02,insider filing director patricia russo,MRK,0.0490371510386467
2020-06-02,insider filing director inge thulin,MRK,0.049750231206417
2020-06-02,director bought show helps cause speaks,MRK,0.9688155651092528
2020-06-02,matthewherper full frazier cnbc interview watch whole thing,MRK,0.3161298930644989
2020-06-02,insider filing director peter wendell,MRK,0.0535744428634643
2020-06-02,acquired thulin inge director reported form filed,MRK,0.2079410851001739
2020-06-02,acquired craig pamela director reported form filed,MRK,0.1742845028638839
2020-06-02,semodough baml concerned about dominant positioning keytruda monotherapy high patients emphasized,MRK,0.7166279554367065
2020-06-02,engulfing pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-0.6842824220657349
2020-06-02,nice column multi sector against timing waited what bring covid fight,MRK,0.9856430292129515
2020-06-02,frazier dominates,MRK,-0.0632553920149803
2020-06-02,baml concerned about dominant positioning keytruda monotherapy high patients emphasized room activity novel agents combowith antibodies think wood chop before tigit meaningful competitor,MRK,0.9230625629425048
2020-06-02,became major player global push develop medicines against covid daria hazuda vice president infectious disease discovery spoke biopharma dive about company plans,MRK,0.4557946622371673
2020-06-02,time breakout getter what real,MRK,-1.027090549468994
2020-06-02,horse race after nice surprise,MRK,0.941887617111206
2020-06-02,powerful statements biggest names pharma,MRK,0.9726119041442872
2020-06-02,full frazier cnbc interview watch whole thing,MRK,0.3348907828330993
2020-06-02,bought,MRK,0.918687105178833
2020-06-02,pharma chart leadership long term pipeline drugs approved development current valuation compared time highs definitely attractive,MRK,0.9820141792297364
2020-06-02,full interview frazier cnbc everyone watch business beyond statements step address world continuing results years years racial prejudice country yazddvfpya,MRK,-0.003077570348978
2020-06-02,moved above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9073276519775392
2020-06-02,what need black daughter after killing george floyd,MRK,-0.7712883949279785
2020-06-02,sold blackhill capital,MRK,-0.8679413795471191
2020-06-02,frazier philly,MRK,0.0261855088174343
2020-06-02,george floyd,MRK,0.060929786413908
2020-06-02,simply short,MRK,-1.0522643327713013
2020-06-02,profound genuine statement made regarding recent acts against black mortality long kenneth frazier george floyd,MRK,-0.0447898432612419
2020-06-02,movement taownpntdh,MRK,0.5261485576629639
2020-06-02,thomas white international makes ffvfghqukl,MRK,0.1381452083587646
2020-06-03,powerhouse team preparing leap past roche leave gilead bristol myers behind race tigit domination alooswaebd,MRK,-0.0959719344973564
2020-06-03,congratulations,MRK,0.4177019894123077
2020-06-03,presents asco slideshow finance business,MRK,-0.0002796277403831
2020-06-03,rising volume pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-0.0249098464846611
2020-06-03,buys coming,MRK,0.9252253770828248
2020-06-03,semodough continue adjuvant potential upside driver longer term keytruda estimates provided updates,MRK,0.9803080558776855
2020-06-03,already brands index only pharma bios,MRK,-0.4278790056705475
2020-06-03,noahweiland sangernyt studies safety efficacy humans begin,MRK,0.6413919925689697
2020-06-03,third covid program antiviral ridgeback vaccine,MRK,-0.9634171724319458
2020-06-03,continue adjuvant potential upside driver longer term keytruda estimates provided updates clinical program adjuvant neoadjuvant indications studies running represent upside keytruda longer term slidedeck,MRK,0.9843202829360962
2020-06-03,pick every single time,MRK,0.2044140994548797
2020-06-03,nice call marknewtoncmt,MRK,0.9298831224441528
2020-06-03,article doesn indicate which vaccine programs selected,MRK,0.0129048340022563
2020-06-03,rest pharma sector moves help takes village raise sector know progresses,MRK,0.9903885126113892
2020-06-03,looking watch list clearly track direction helping encourage finally,MRK,0.9704525470733644
2020-06-03,strong movement,MRK,0.9617429971694946
2020-06-03,happy director bought jamie diamond bought outright changes game glta,MRK,0.9593772888183594
2020-06-03,looks these flash treatments fading fast does well working platforms prudent moves long strong,MRK,0.9609931707382202
2020-06-03,strong,MRK,0.9570066928863524
2020-06-03,sold calls gain possibly enter pullback strong enough otherwise hands chill,MRK,0.9105724096298218
2020-06-03,optimus maximus closed covered previously shorted loss corp stats,MRK,-1.0748273134231567
2020-06-03,inside,MRK,0.0298413187265396
2020-06-03,insider filing director pamela craig,MRK,0.0473060384392738
2020-06-03,moved above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9073276519775392
2020-06-03,expected sales billion,MRK,0.0780007094144821
2020-06-03,expected sales billion,MRK,0.0780007094144821
2020-06-03,insider filing director thomas cech,MRK,0.0474987514317035
2020-06-03,waited what bring covid fight,MRK,-0.06973247975111
2020-06-03,acquired wendell peter director reported form filed yqpbmupbdt,MRK,0.1824139058589935
2020-06-03,acquired warden kathy director reported form filed,MRK,0.1850991994142532
2020-06-03,form initial statement beneficial ownership securities filed,MRK,0.7626422643661499
2020-06-03,acquired lavizzo mourey risa director reported form filed,MRK,0.2346840351819992
2020-06-03,acquired seidman christine director reported form filed,MRK,0.185028076171875
2020-06-03,acquired brun leslie director reported form filed,MRK,0.2118686586618423
2020-06-03,acquired cech thomas director reported form filed,MRK,0.1561015844345092
2020-06-03,acquired mary ellen director reported form filed,MRK,0.1930857300758361
2020-06-03,acquired glocer thomas director reported form filed,MRK,0.1783276498317718
2020-06-03,acquired rothman paul director reported form filed taifpvaxaa,MRK,0.1789126992225647
2020-06-03,acquired russo patricia director reported form filed,MRK,0.161012202501297
2020-06-03,acquired craig pamela director reported form filed,MRK,0.1742845028638839
2020-06-03,acquired wendell peter director reported form filed,MRK,0.1824139058589935
2020-06-03,acquired warden kathy director reported form filed,MRK,0.1850991994142532
2020-06-03,insider filing director kathy warden,MRK,0.0511661581695079
2020-06-03,acquired thulin inge director reported form filed,MRK,0.2079410851001739
2020-06-03,king wealth million holdings,MRK,0.1927912831306457
2020-06-03,king wealth million holdings,MRK,0.1927912831306457
2020-06-03,insider filing director mary ellen,MRK,0.0507217086851596
2020-06-03,insider filing director thomas glocer,MRK,0.0464786365628242
2020-06-03,seekingalpha management presents oncology event asco conference transcript,MRK,-0.0457907058298587
2020-06-03,elfun trusts keeps,MRK,0.1306118965148925
2020-06-03,management presents oncology event asco conference transcript economy,MRK,-0.020249493420124
2020-06-03,awesome chart company looks strong,MRK,0.9667454957962036
2020-06-04,earnings expected quarter,MRK,0.4238735735416412
2020-06-04,briefingcom approves recarbrio treatment hospital acquired ventilator associated bacterial pneumonia,MRK,-0.0032057985663414
2020-06-04,approves recarbrio treatment hospital acquired ventilator associated bacterial pneumonia,MRK,0.0429233238101005
2020-06-04,moat wider deeper good work reason wants part virus patrol agreed work hard vaccine,MRK,0.9733588695526124
2020-06-04,another winner,MRK,0.9670529365539552
2020-06-04,combo antibiotic bacterial pneumonia,MRK,0.0320371054112911
2020-06-04,combo antibiotic bacterial pneumonia,MRK,0.0320371054112911
2020-06-04,sold purchased,MRK,-1.0014921426773071
2020-06-04,cnbcfastmoney crook insider keep selling,MRK,-1.0378276109695437
2020-06-04,cnbcfastmoney insider selling,MRK,-1.0102906227111816
2020-06-04,icymi major player global push develop medicines against covid daria hazuda vice president infectious disease discovery spoke benthefidler about plans,MRK,0.4124458134174347
2020-06-04,july call volume,MRK,0.1518163233995437
2020-06-04,cnbcfastmoney insider keep selling,MRK,-1.019473433494568
2020-06-04,dividend coming,MRK,0.3815264999866485
2020-06-04,booming raid,MRK,-0.7163790464401245
2020-06-04,point were lift long strong value,MRK,0.9721336364746094
2020-06-04,excellent technical analysis score score breakdown categories candle score excellent moving average score excellent momentum score excellent stockmarket,MRK,0.961639165878296
2020-06-04,moved above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9073276519775392
2020-06-04,ymuer,MRK,-0.0100626088678836
2020-06-05,biostocks approves recarbio treatment adults hospital acquired ventilator associated bacterial pneumonia,MRK,0.0610473863780498
2020-06-05,cnbcfastmoney insider selling,MRK,-0.9817215204238892
2020-06-05,delta expiration maxpain options,MRK,-0.0174848027527332
2020-06-05,looking,MRK,0.643589973449707
2020-06-05,expiration maxpain high open interest high call open interest,MRK,0.9199199676513672
2020-06-05,navellier associates sells,MRK,-0.6949812173843384
2020-06-05,merckco bidaskscore increased held,MRK,0.9245249032974244
2020-06-05,watching push slightly sloppy nonetheless squeeze firing long planning take common move needs clearance aottrades,MRK,-1.0468721389770508
2020-06-05,proud latest news infectiousdiseases beuemmymdt,MRK,0.9492326974868774
2020-06-05,juliaskripkaser cloisterres long,MRK,0.5988837480545044
2020-06-05,great dogs,MRK,0.9784914255142212
2020-06-05,hole village move,MRK,0.545180082321167
2020-06-05,recarbrio imipenem cilastatin relebactam received approval treatment adults,MRK,0.0661539584398269
2020-06-05,think,MRK,-0.0055695585906505
2020-06-05,datatrials approves recarbrio imipenem cilastatin relebactam treatment adults hospital,MRK,0.0304335728287696
2020-06-05,approves recarbrio imipenem cilastatin relebactam treatment adults hospital acquired ventilator associated bacterial pneumonia habp vabp,MRK,0.0873606652021408
2020-06-05,approves recarbrio imipenem cilastatin relebactam treatment adults hospital acquired ventilator associated bacterial pneumonia habp vabp,MRK,0.0600309520959854
2020-06-05,chitraders approves recarbrio imipenem cilastatin relebactam treatment adults hospital acqui,MRK,0.1459042429924011
2020-06-05,approves recarbio treatment adults hospital acquired ventilator associated bacterial pneumonia,MRK,0.0770873874425888
2020-06-05,delayed issued press release june approves recarbrio imipenem cilastatin relebactam treatment adults hospital acquired ventilator associated bacterial pneumonia habp vabp,MRK,-0.5837371349334717
2020-06-05,proud latest news infectiousdiseases beuemmymdt,MRK,0.9549766778945924
2020-06-05,approves recarbrio imipenem cilastatin relebactam treatment adults hospital acquired ventilator associated bacterial pneumonia habp vabp,MRK,0.0873606652021408
2020-06-05,moved above moving average view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9073276519775392
2020-06-06,wins third antibiotic mereo tackles tigit raise hand,MRK,0.8056448698043823
2020-06-06,slower than peers edges into covid fight,MRK,-1.0302793979644775
2020-06-06,alphacrest capital management grows holdings,MRK,0.6432946920394897
2020-06-06,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news xujqhphjjk,MRK,0.9489938020706176
2020-06-06,options power options maxpain chart open interest chart update optionstrading optionsflow stockmarket,MRK,0.5358395576477051
2020-06-07,saturna capital corp acquires,MRK,0.2512500286102295
2020-06-07,delta management buys,MRK,0.2151997685432434
2020-06-07,acquired westpac banking corp,MRK,0.3776184916496277
2020-06-07,sold wintrust investments cmlhmzjljf,MRK,-0.886432409286499
2020-06-07,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-06-07,mcmontys collaboration discover develop proprietary influenza antiviral agents program provide,MRK,-0.0761068984866142
2020-06-08,matthewherper blockbuster stat conversations double header helenbranswell interview julie gerberding,MRK,-0.0798584595322609
2020-06-08,jeff interconnected interest ensuring good health around world prevent these types spreads really decimate populations biodigital,MRK,0.9370216131210328
2020-06-08,bfirozbahary dont think about about fomo excitment coinbasepro think real catalyst into coinbase seeing knows maybe into cheers mate,MRK,0.840701699256897
2020-06-08,note manufacturing figures percentages jeff cited drugs apis made versus overseas conflicts what oigathhs reported biodigital,MRK,-0.2708495855331421
2020-06-08,jeff insists came into pandemic time strength didn happen overnight result policies encouraged biotech which gold standard world academic institutions incentivized through bayh dole biodigital,MRK,0.9632953405380248
2020-06-08,international times covid brian pomper asiapolicy wendyscutler jeff keepitmadeinusa scottpaulaam keith rockwell exports pomper mind introduced speakers panel exports biodigital,MRK,0.0304485633969306
2020-06-08,movement entered always step ahead crowd ggvidhxnfq,MRK,0.7238715887069702
2020-06-08,bought,MRK,0.8680386543273926
2020-06-08,ready,MRK,0.4678103029727936
2020-06-08,blockbuster stat conversations double header helenbranswell interview julie gerberding about company efforts caseymross interview director seema verma olhumxvvqt,MRK,-0.064762182533741
2020-06-08,global wealth management advisory raises position,MRK,0.7267651557922363
2020-06-08,keeping eyes stays,MRK,0.2457464188337326
2020-06-08,headed soon,MRK,0.0262070223689079
2020-06-08,expiration maxpain high open interest high call open interest,MRK,0.8925349712371826
2020-06-08,drmichellebio notes tonycolesmd young scientist created fellowship program thanks leading opportunities african american scientists talent wasted unless fostered progress made greatness achieved biodigital,MRK,0.597527265548706
2020-06-08,drmichellebio first generation scientist wasn prepared politics science weight began mount biotech wrapped arms around notes industry fellowship rescued biodigital,MRK,0.8472957611083984
2020-06-08,simply outstanding well thought company,MRK,0.965961217880249
2020-06-08,uptrend moving average convergence divergence macd histogram turned positive view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.960663914680481
2020-06-08,black father processes killing george floyd another black father fgonomwfrc,MRK,-0.6887054443359375
2020-06-09,recent bladdercancer update zubwdaumif,MRK,-0.0123626105487346
2020-06-09,update bladder cancer late stage study fails meet main goals bjgmaxagrl,MRK,-1.0668680667877195
2020-06-09,briefingcom provides update phase keynote trial keytruda monotherapy combination,MRK,-0.0229270756244659
2020-06-09,provides update phase keynote trial keytruda monotherapy combination,MRK,0.0147632323205471
2020-06-09,keytruda flunks first line bladder cancer study,MRK,-0.0603653937578201
2020-06-09,phase keynote trial evaluating keytruda meet specified dual primary endpoints,MRK,-0.5562952756881714
2020-06-09,zbiotech keynote trial evaluating keytruda combination chemotherapy first line treatment patients,MRK,0.115538015961647
2020-06-09,keytruda flunks first line bladder cancer study,MRK,-0.0603653937578201
2020-06-09,give sentiment score scale moderate activity social media recently mvyihyzlva,MRK,-0.9804586172103882
2020-06-09,john markels running full capacity pandemic strikes search cupboards what biodigital vaccines,MRK,-0.0808039084076881
2020-06-09,dark cloud cover pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-1.0074998140335083
2020-06-09,donnayoungdc julie gerberding what thing worry about vaccine nationalism everybody concerne,MRK,-0.4578191041946411
2020-06-09,provides update phase keynote trial evaluating keytruda pembrolizumab monotherapy,MRK,0.1532113254070282
2020-06-09,john markels technical human resources vaccinologists limited resource people make work trouble biodigital vaccines,MRK,-0.93253493309021
2020-06-09,john markels about making vaccine about characteristics make sure scaleable usable idea platform powerful biodigital vaccines,MRK,1.002690076828003
2020-06-09,markels those things typically done years trying months enough capacity manufacture scale needs mechanism time identify leading candidates help make decisions move capacity impact biodigital,MRK,0.9210430383682252
2020-06-09,john markels what doing kitchen sink everybody trying what find scale quickly throwing kitchen sink billion vaccine already intensive biodigital vaccines,MRK,0.0421261712908744
2020-06-09,john markels less vaccine industry running capacity additional excess capacity around takes long time build context which embarking ambitious efforts biodigital vaccines,MRK,0.4225063025951385
2020-06-09,oops well words wisdom stonks tgqgeuioxk,MRK,0.2732812464237213
2020-06-09,recent bladdercancer update zubwdaumif,MRK,-0.0353539884090423
2020-06-09,phase keynote trial evaluating keytruda meet specified dual primary endpoints,MRK,-0.7986994981765747
2020-06-09,keynote trial evaluating keytruda combination chemotherapy first line treatment patients advanced metastatic urothelial carcinoma bladder cancer meet specified dual primary endpts,MRK,0.1637472212314605
2020-06-09,john markels feel special responsibility side humans side mindless virus race against virus developing safe effective vaccine daunting challenge scale times than ebola biodigital,MRK,0.3474015891551971
2020-06-09,expiration maxpain high open interest high call open interest,MRK,0.9177098274230956
2020-06-09,zekesmommaskid killed times already uniswapprotocol best friends along coinbase,MRK,0.9982141256332396
2020-06-09,donnayoungdc julie gerberding chose platforms experience safety true rare events,MRK,0.8382912874221802
2020-06-09,matthewherper vaccine optimist case says gerberding reason vaccines against animal coronaviru,MRK,-0.0707671046257019
2020-06-09,matthewherper gerberding enough information know neutralizing antibodies alone enough approval,MRK,0.1384340226650238
2020-06-09,matthewherper gerberding former director says treasure chest experts hopes good work being,MRK,0.6401293277740479
2020-06-09,julie gerberding collaboration willingness help each inspiring think commitment wants company keeps product only rich vaccines,MRK,1.0208832025527954
2020-06-09,ensuring equitable distribution vaccines julie gerberding coalition construct wish global apparatus best thing cepivaccines gavi help vulnerable countries middle income countries hardest engage,MRK,0.6884496212005615
2020-06-09,donnayoungdc hard test vaccines vaccines candidates gerberding transmission faster,MRK,-0.7420104742050171
2020-06-09,julie gerberding vaccines important time engagement women childbearing conversation often culturally dependent,MRK,0.3250795900821686
2020-06-09,julie gerberding fast shortchange safety assessment compressing timeline safety important skipping safety assessments vaccines,MRK,0.9209284782409668
2020-06-09,julie gerberding chose platforms experience safety true rare events seen until vaccines given track record racing vaccines public health emergency good,MRK,0.9288203716278076
2020-06-09,julie gerberding what thing worry about vaccine nationalism everybody concerned about being first protecting country safe until everyone safe vaccines,MRK,0.5817309617996216
2020-06-09,higher dose vaccine needed julie gerberding reason chose vaccines chose likely illicit broad response need than vaccine notes populations need type protected another,MRK,0.2484798580408096
2020-06-09,julie gerberding feel comfortable challenge trial treatment knew worked zero risk groups affected virus immune serious outcome death vaccines,MRK,0.9088351726531982
2020-06-09,hard test vaccines vaccines candidates gerberding transmission faster answer efficacy unfortunately plenty spots surprised global situation pretty grim,MRK,-0.9737523794174194
2020-06-09,both single dose vaccines julie gerberding until work know answer question vaccines,MRK,0.0053456239402294
2020-06-09,donnayoungdc realistic timelines gerberding platform dependent decision approaches faster scale than,MRK,0.3420658111572265
2020-06-09,realistic timelines gerberding platform dependent decision approaches faster scale than gate successful ultimately about what protect science stern task master things always turn,MRK,0.8629438877105713
2020-06-09,julie gerberding surprised vaccine without neutralizing antibody something learn studies vaccines,MRK,0.2913084030151367
2020-06-09,gerberding alignment around global threat humans human economy overcomes territorial competitive ways usually things same time stay safe vaccines,MRK,0.800841212272644
2020-06-09,gerberding enough information know neutralizing antibodies alone enough approval live chat,MRK,-0.0057003796100616
2020-06-09,gerberding those partnerships came into being during ebola didn exist ahead kind messy coordinate people world trials environments never participating everyone same page heroic lots people came together,MRK,0.8245813846588135
2020-06-09,vaccine optimist case says gerberding reason vaccines against animal coronaviruses which seen proof concept people take them,MRK,-0.3572551310062408
2020-06-09,julie gerberding emerged process figured drug vaccinate against learned tremendous amount retroviruses knowledge informed drug helped understand approach viruses vaccines,MRK,0.4804725646972656
2020-06-09,always pathogens haven imagined apparatus allows proceed quickly than past julie gerberding having invent vaccines fast,MRK,-0.3266176879405975
2020-06-09,julie gerberding always pathogens haven imagined platform approach pursue fast vaccines,MRK,-0.1218217089772224
2020-06-09,timeline gerberding everyone understands time work parallel series vaccine never fast want safety studies easy test environment cases measles construct trials weeks iavi later,MRK,-0.4559111297130584
2020-06-09,julie gerberding important thing safety closely related vaccines behave differently work safety vaccines,MRK,0.7038638591766357
2020-06-09,gerberding former director says treasure chest experts hopes good work being done gets,MRK,0.6141782999038696
2020-06-09,julie gerberding doubt vaccine race hopefully something help everyone protected vaccines,MRK,0.7624894380569458
2020-06-09,julie gerberding doubt vaccine race everyone talking about think benefit having than vaccine come listen,MRK,0.9357261657714844
2020-06-09,gerberding quest find candidates took time looking vaccine effective dose distributed anyone world tall order candidate based measles iavi same backbone ebola tried true,MRK,0.9012625217437744
2020-06-09,julie gerberding scientists treasure chest capability trusted vaccines,MRK,0.8045504093170166
2020-06-09,julie gerberding impossible think back sars little dodge bullet devastating mortality impact economy harbinger taken heart better position,MRK,0.8083093166351318
2020-06-09,adamfeuerstein stat conversations helenbranswell speaks julie gerberding about,MRK,-0.0711447894573211
2020-06-09,strugling near sell fail,MRK,-1.0726689100265503
2020-06-09,optimus maximus shorted opened corp chance loss hold stats,MRK,0.8749871253967285
2020-06-09,stat conversations helenbranswell speaks julie gerberding about company work caseymross interviews director seema verma,MRK,-0.0422684550285339
2020-06-09,pain maturity maxpain options,MRK,-0.0214879959821701
2020-06-09,uptrend moving average convergence divergence macd histogram turned positive view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.960663914680481
2020-06-09,showed strong momentum monday score,MRK,0.9627331495285034
2020-06-09,bought banque cantonale vaudoise,MRK,0.6771937608718872
2020-06-09,stake lowered grantham mayo otterloo,MRK,-0.8853225708007812
2020-06-09,downgraded valuengine,MRK,-1.0064295530319214
2020-06-09,downgraded valuengine,MRK,-1.0064295530319214
2020-06-10,jasonfieber what thesis entry into particular point know solid well curious what seeing moment,MRK,0.8026173114776611
2020-06-10,risk reversal alert puts finance buying calls,MRK,-0.493950217962265
2020-06-10,asset management decreases stake,MRK,-0.8969180583953857
2020-06-10,adamtatusko stash does mean stashstockparty back giveaway taken before,MRK,-1.0075125694274902
2020-06-10,stash does mean stashstockparty back giveaway taken before timer elapses,MRK,-1.0218929052352903
2020-06-10,pharmamaven bsgm swing sell conf call spring former lead worldwide live viral vaccine franchise talks vacci,MRK,-0.9728320837020874
2020-06-10,decided jump reason mentions,MRK,0.907631516456604
2020-06-10,approval phase trials bcgvaccine hope helps fight against,MRK,0.7582602500915527
2020-06-10,keytruda fails pivotal bladder cancer study sinks first line hopes frankvinluan,MRK,-0.9717748165130616
2020-06-10,dividend june,MRK,-0.0587130784988403
2020-06-10,drop below always contracts days less risky,MRK,-1.0775948762893677
2020-06-10,sold fail break,MRK,-1.0519912242889404
2020-06-10,provides update trial keytruda chemotherapy first line treatment advanced metastatic urothelialcarcinoma meet specified dual primary endpoints overall survival progression free survival,MRK,0.755253791809082
2020-06-10,lyvgen announces clinical trial collaboration hppzaebevm,MRK,0.0667859315872192
2020-06-10,moved above moving average view odds indicators stockmarket technicalanalysis money daytrading news srzhztvotu,MRK,0.9073276519775392
2020-06-10,keytruda fails meet endpoints bladder cancer trial,MRK,-1.042377233505249
2020-06-10,full analysis interesting early analysis shown decreased lows keytruda which driven fail result suggests benefit highs either,MRK,-0.4805803000926971
2020-06-10,merckco bidaskscore lowered sold,MRK,-0.9709243774414062
2020-06-10,king keytruda flounders another pivotal cancer study spur doubts about staying power,MRK,-0.9898271560668944
2020-06-10,downgraded valuengine sell,MRK,-0.9645098447799684
2020-06-10,rating lowered sell valuengine,MRK,-0.8615813255310059
2020-06-10,rating lowered sell valuengine,MRK,-0.8615813255310059
2020-06-10,implied volatility expiration maxpain options,MRK,-1.0686988830566406
2020-06-10,directional bias report click details,MRK,-0.7779198884963989
2020-06-10,report click sell,MRK,0.2802823483943939
2020-06-10,provides update phase keynote trial evaluating keytruda monotherapy combination chemotherapy patients advanced metas,MRK,0.3187370896339416
2020-06-10,keytruda flunks first line bladder cancer study qzbhzmxjui,MRK,-0.47800013422966
2020-06-10,bladder cancer late stage study fails meet main goals,MRK,-1.0683766603469849
2020-06-11,optimus maximus closed covered previously shorted profit corp stats,MRK,0.8058840036392212
2020-06-11,stash previously stated announce before stashstockparty giveaway,MRK,0.0274612382054328
2020-06-11,lower higher volume pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-0.6859983205795288
2020-06-11,optimus maximus closed covered previously shorted profit corp stats,MRK,0.7913484573364258
2020-06-11,stashstockparty free sign,MRK,0.9598990678787231
2020-06-11,free,MRK,0.8598699569702148
2020-06-11,stanholtsclaw stashstockparty come folks,MRK,0.7359155416488647
2020-06-11,stashstockparty back baby merc join,MRK,0.375318169593811
2020-06-11,downgraded valuengine,MRK,-1.0064295530319214
2020-06-11,superstockparty alarms stashstockparty stash,MRK,-0.1132758259773254
2020-06-11,issue dividend,MRK,0.0730031877756118
2020-06-11,optimus maximus shorted opened corp chance loss hold stats,MRK,0.880163311958313
2020-06-11,option,MRK,0.6612104177474976
2020-06-11,sold,MRK,-0.9084740877151488
2020-06-11,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-06-11,increased times years,MRK,0.9683725833892822
2020-06-11,sqwii take care data phase dont really setup into data bearish take care,MRK,-1.0635677576065063
2020-06-11,short interest update,MRK,0.5268117189407349
2020-06-11,short interest update,MRK,0.4380169808864593
2020-06-11,short interest update,MRK,0.4380169808864593
2020-06-13,indication vaccine,MRK,0.153319850564003
2020-06-13,approves prevention certain hpvrelated headandneckcancers,MRK,-0.3597398102283478
2020-06-13,autonomouscns indication vaccine,MRK,0.1437909007072448
2020-06-13,check latest news,MRK,0.2677736580371856
2020-06-13,indication vaccine,MRK,0.153319850564003
2020-06-13,lowered peer perform wolfe research,MRK,-0.87813401222229
2020-06-13,peak profit expired option alerts,MRK,0.6875190734863281
2020-06-13,months option alerts peaked above after were triggered algo,MRK,0.919970154762268
2020-06-13,view historical options performance,MRK,0.0985150188207626
2020-06-13,formulafolio investments buys,MRK,0.1628884375095367
2020-06-13,keytruda blockbuster seller drug failed phase test hoped support expanding approval first line treatment common form bladder cancer xidfomhmli immunotherapy,MRK,-1.0038353204727173
2020-06-13,marketcurrents indication vaccine,MRK,0.1437909007072448
2020-06-13,indication vaccine,MRK,0.1202854216098785
2020-06-13,indication vaccine,MRK,0.153319850564003
2020-06-13,upcoming event june prescription drug pdufa options expiring june cover event implied move,MRK,0.2920418381690979
2020-06-13,approves prevention certain hpvrelated headandneckcancers,MRK,-0.4560896754264831
2020-06-14,capital financial corp invests,MRK,-0.722028374671936
2020-06-14,gamco increases position,MRK,0.8799710273742676
2020-06-14,titanic theme song,MRK,-0.0413742512464523
2020-06-14,capital financial corp invests,MRK,-0.722028374671936
2020-06-14,ahead biotech decisions cards epizyme evoke ultragenyx sbqqeqlxav xdzacqjgaw,MRK,0.0446361042559146
2020-06-14,rating lowered peer perform wolfe research beevxvbyas,MRK,-0.90411639213562
2020-06-14,indication vaccine ijyvvcoayy,MRK,0.1202854216098785
2020-06-15,downtrend stochastic indicator reaching oversold zone view odds indicators stockmarket technicalanalysis money daytrading news,MRK,-1.073868989944458
2020-06-15,falling fast,MRK,-1.0126718282699585
2020-06-15,lower higher volume pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-0.6807560920715332
2020-06-15,major breakdown pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-0.921917200088501
2020-06-15,minor breakdown pattern appearances since performance close days later worst best days later worst best days later worst best,MRK,-0.9430171251296996
2020-06-15,think good cancer drug keytruda meet goals study involving bladder cancer patients keytruda already approved types cancer sales than billion yexlrxdypf,MRK,1.0012317895889282
2020-06-15,closes lower sentiment bearish,MRK,-1.0779763460159302
2020-06-15,slippery path,MRK,0.1799907982349395
2020-06-15,covemgmt decision curious which good news usually makes thes,MRK,0.9412318468093872
2020-06-15,huge variation company common,MRK,-1.0125380754470823
2020-06-15,gess continue cases virus,MRK,-0.1622416228055954
2020-06-15,huge variation company common,MRK,-1.021389365196228
2020-06-15,decision curious which good news usually makes these days svacctsolution investments money,MRK,0.9867388010025024
2020-06-15,recent technical alerts macd bearish signal line cross plus alerts,MRK,-1.0465751886367798
2020-06-15,delta expiration maxpain options exneuquvpp,MRK,-0.0184644982218742
2020-06-15,huge variation company common,MRK,-1.0124911069869995
2020-06-15,slippery path,MRK,0.3069656193256378
2020-06-15,what hitting significant underperformer fear deal exaggerated,MRK,-0.8785953521728516
2020-06-15,pump dump,MRK,-0.8612394332885742
2020-06-15,huge variation company common,MRK,-1.030714988708496
2020-06-15,caetuscap similar sessions,MRK,-0.8344316482543945
2020-06-15,sold,MRK,-1.029625415802002
2020-06-15,early phase pembrolizumab plus radioembolization subjects estimated primary completion date,MRK,0.0003344230353832
2020-06-15,huge variation company common,MRK,-1.0120248794555664
2020-06-15,phase study olaratumab plus pembrolizumab participants advanced metastatic soft tissue sarcoma estimated primary completion date,MRK,0.3708139061927795
2020-06-15,phase safety tolerability immunogenicity healthy japanese infants estimated primary completion date,MRK,0.90582537651062
2020-06-15,phase metastatic locally advanced solid tumors estimated primary completion date,MRK,0.8155883550643921
2020-06-15,phase first human solid tumors estimated primary completion date,MRK,0.8830742835998535
2020-06-15,phase study avelumab combinations estimated primary completion date,MRK,-0.0343617834150791
2020-06-15,added update fire fund early july reflect transaction dividends money fire passiveincome earlyretirement,MRK,0.6680814027786255
2020-06-15,jimcramer,MRK,0.4042727351188659
2020-06-15,building merckformothers efforts expanding saferchildbirthcities initiative help endmaternalmortality narrow disparities learn,MRK,-0.0643595308065414
2020-06-15,briefingcom receives approval gardasil,MRK,0.1141721680760383
2020-06-15,receives approval gardasil,MRK,0.2558662593364715
2020-06-15,wolfe research lowers peer perform,MRK,-0.3891726732254028
2020-06-15,wolfe research lowers peer perform,MRK,-0.17424938082695
2020-06-15,wolfe research lowers peer perform fwmsnovulr,MRK,-0.17424938082695
2020-06-15,gardasil receives expanded cancer indications,MRK,0.0078082904219627
2020-06-15,gamco increases position,MRK,0.8799710273742676
2020-06-16,keytruda second application based biomarker,MRK,0.0147283375263214
2020-06-16,click latest research,MRK,0.325564444065094
2020-06-16,sells notes notes notes notes notes,MRK,-0.9345500469207764
2020-06-16,good hands mreck,MRK,0.9655413627624512
2020-06-16,winners,MRK,0.9520018100738524
2020-06-16,keytruda second application based biomarker pxkdubzbms,MRK,0.0178725346922874
2020-06-16,keytruda second application based biomarker,MRK,0.0167210735380649
2020-06-16,timothysykes waiting,MRK,0.2786859273910522
2020-06-16,high volume stay course,MRK,0.9663763046264648
2020-06-16,perhaps something after close news,MRK,0.0260648094117641
2020-06-16,huge variation company common,MRK,0.5143884420394897
2020-06-16,briefingcom present results phase vertis trial patients type diabetes,MRK,0.0105826407670974
2020-06-16,huge variation company common,MRK,0.4941207766532898
2020-06-16,present results phase vertis trial patients type diabetes mwjrxdmwum,MRK,-0.0104704275727272
2020-06-16,huge variation company common,MRK,0.3856576085090637
2020-06-16,downtrend moving average convergence divergence macd histogram crosses below signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,-1.0743948221206665
2020-06-16,huge variation company common,MRK,0.3772499859333038
2020-06-16,huge variation company common,MRK,0.5816917419433594
2020-06-16,,MRK,0.9800909757614136
2020-06-16,huge variation company common,MRK,0.5011333227157593
2020-06-16,,MRK,0.9836968183517456
2020-06-16,thought cancer treatment,MRK,-0.4138332605361938
2020-06-16,what expected,MRK,-0.3124161064624786
2020-06-16,huge variation company common,MRK,0.5203704833984375
2020-06-16,huge variation company common,MRK,0.533031702041626
2020-06-16,inhibitor steglatrotm ertugliflozin meets primary endpoint vertis trial,MRK,-0.0730490237474441
2020-06-16,call options,MRK,0.1443413347005844
2020-06-16,click latest research,MRK,0.3176840543746948
2020-06-16,huge variation company common,MRK,0.3771114349365234
2020-06-16,huge variation company common,MRK,0.5613536834716797
2020-06-16,bought call contract,MRK,0.944632649421692
2020-06-16,cheddarflow unusual call sweep june calls opened premium,MRK,-0.2593541443347931
2020-06-16,unusual call sweep june calls opened premium,MRK,-0.7212380170822144
2020-06-16,phase study zoledronic acid pravastatin lonafarnib patients progeria estimated primary completion date,MRK,-0.0233194418251514
2020-06-16,phase phase neoadjuvant pembrolizumab combination gemcitabine therapy eligible ineligible subjects estimated primary completion date,MRK,-0.0758864879608154
2020-06-16,phase pembrolizumab locally delivered radiation therapy treatment metastatic esophageal cancers estimated primary completion date,MRK,-0.0729965046048164
2020-06-16,phase study pembrolizumab gvax sbrt patients locally advanced pancreatic cancer estimated primary completion date,MRK,0.0317372605204582
2020-06-16,phase study azacitidine combination pembrolizumab relapsed refractory acute myeloid leukemia patients newly diagnosed older years patients estimated primary completion date,MRK,0.098348282277584
2020-06-16,phase study pembrolizumab combination trastuzumab estimated primary completion date,MRK,0.0064963065087795
2020-06-16,phase safety tolerability efficacy doxorubicin pembrolizumab sarcoma estimated primary completion date,MRK,0.3521390259265899
2020-06-16,poor technical analysis score score breakdown categories candle score neutral moving average score poor momentum score neutral stockmarket,MRK,-1.0545660257339478
2020-06-16,recent technical alerts macd bearish centerline cross plus alerts,MRK,-1.0456761121749878
2020-06-16,showstopper discord stop,MRK,-1.005721926689148
2020-06-16,paid,MRK,0.5880482196807861
2020-06-16,files form,MRK,-0.0812928080558776
2020-06-16,optimus maximus shorted opened corp chance loss hold stats,MRK,0.8775796890258789
2020-06-16,brand name decadron least answered question part matters,MRK,-0.3934382796287536
2020-06-16,form prospectus rule filed,MRK,-0.0819078683853149
2020-06-16,form prospectus rule filed,MRK,-0.0819078683853149
2020-06-16,announces call proposals second cohort safer childbirth cities expanding maternal health support across cities,MRK,0.3980063498020172
2020-06-16,fail break proven fatal,MRK,-1.0607348680496216
2020-06-16,downgraded peer perform wolfe research,MRK,-1.0045030117034912
2020-06-16,slwsteadystocks investingwbrady hoping back range,MRK,0.2946541011333465
2020-06-16,high range option expiration putcallratio maxpain options,MRK,0.967025876045227
2020-06-16,announces call proposals second cohort safer childbirth cities expanding maternal health support across cities,MRK,0.0573954284191131
2020-06-16,straddle implies move prescription drug pdufa,MRK,0.1539831310510635
2020-06-17,persimmonti srqstockpicker makes sense serious about nash partnered prob capture nash,MRK,-0.3943122923374176
2020-06-17,animal health completes acquisition quantified zhhltxibkj,MRK,0.2417146861553192
2020-06-17,click read latest merckah news,MRK,0.3487266898155212
2020-06-17,andybiotech approves biomarker based indication keytruda regardless tumor type tumor mutational burden high,MRK,0.1438224911689758
2020-06-17,animal health completes acquisition quantified,MRK,0.1973229795694351
2020-06-17,click read latest merckah news,MRK,0.34400075674057
2020-06-17,dark cloud cover appearances since close days later worst best days later worst best days later worst best,MRK,-1.0091986656188965
2020-06-17,hearing weak news,MRK,-1.0729999542236328
2020-06-17,loading boat range bots,MRK,0.7606052160263062
2020-06-17,andybiotech super smart trial design deserve premium,MRK,0.99018657207489
2020-06-17,venturi wealth management buys,MRK,0.1779105216264724
2020-06-17,capitalism change recently,MRK,0.3672540485858917
2020-06-17,approves second biomarker based indication keytruda pembrolizumab regardless tumor type,MRK,0.0487544909119606
2020-06-17,brobertsvc megtirrell least years frazier,MRK,-0.2135026305913925
2020-06-17,billion debt offering,MRK,0.0361474528908729
2020-06-17,debt offering,MRK,0.050540667027235
2020-06-17,witnesses gophelp june hearing bfrist former mike leavitt julie gerberding michiganhhs drkhaldun hearing examine lessons pandemic reminder current pandemic raging,MRK,-0.0512647181749343
2020-06-17,downtrend stochastic indicator staying oversold zone days view odds indicators stockmarket technicalanalysis money daytrading news,MRK,-1.075412392616272
2020-06-17,optimus bought opened corp chance loss hold stats,MRK,0.8566842079162598
2020-06-17,happy wednesday news vaccineswork approves prevent head neck cancer reason,MRK,0.9802229404449464
2020-06-17,expansion moot company outstanding,MRK,0.948078989982605
2020-06-17,optimus maximus shorted opened corp chance loss hold stats,MRK,0.8795170783996582
2020-06-17,optimus maximus closed covered previously shorted loss corp stats,MRK,-1.0774375200271606
2020-06-17,approved keytruda monotherapy treatment adult pediatric patients unresectable metastatic tumor mutational burden high solid tumors progressed prior treatment,MRK,0.9210308790206908
2020-06-17,priced billion public offering series senior unsecured notes mtywccfwdn,MRK,0.1552626490592956
2020-06-17,searching found owns trademark,MRK,0.2028358280658722
2020-06-17,debt offering,MRK,0.2437860816717147
2020-06-17,keytruda second application based biomarker uyisjlkpwg,MRK,0.1441584527492523
2020-06-17,inhibitor steglatrotm ertugliflozin meets primary endpoint vertis trial patients type diabetes atherosclerotic cardiovascular disease,MRK,-0.0346265509724617
2020-06-17,approves second biomarker based indication keytruda,MRK,0.0304619818925857
2020-06-17,approves second biomarker based indication keytruda pembrolizumab regardless tumor type,MRK,0.0487544909119606
2020-06-17,sbwcws approves second biomarker based indication keytruda,MRK,0.0398697145283222
2020-06-17,happy wednesday news vaccineswork approves prevent head neck cancer reason rush teens doctor them vaccinated save them cancer unemployed oncologist good thing,MRK,0.9838813543319702
2020-06-17,part bond offering,MRK,0.0098437368869781
2020-06-17,commitment helping expand options cancer patients continues learn about latest approval,MRK,0.7116070985794067
2020-06-17,approves second biomarker based indication keytruda regardless tumor type,MRK,0.0399284437298774
2020-06-17,approves second biomarker based indication keytruda regardless tumor type,MRK,0.0379395671188831
2020-06-17,click latest news,MRK,0.3904753923416137
2020-06-17,approves second biomarker based indication keytruda,MRK,0.0470847561955452
2020-06-17,approves second biomarker based indication keytruda regardless tumor type,MRK,0.0379395671188831
2020-06-17,approves second biomarker based indication keytruda pembrolizumab regardless tumor type,MRK,0.0599551871418952
2020-06-17,billion debt offering,MRK,0.0361474528908729
2020-06-17,debt offering,MRK,0.0454384908080101
2020-06-17,debt offering,MRK,0.0454384908080101
2020-06-17,debt offering,MRK,0.0768396854400634
2020-06-17,form filing securities rules free writing prospectuses filed,MRK,0.5743820667266846
2020-06-17,recallpropecia quarantine hasn propecia sure,MRK,0.1579214930534362
2020-06-17,quarantine hasn propecia sure,MRK,0.2063888609409332
2020-06-17,nice candy continue,MRK,0.9623426198959352
2020-06-17,huge variation company common,MRK,0.6083700656890869
2020-06-17,options flow grid update optionstrading optionsflow stockmarket healthcare cprmzciypu,MRK,0.854638934135437
2020-06-17,genecollector keytruda second application based biomarker,MRK,0.0123783536255359
2020-06-18,keytruda nabs biomarker driven regardless tumor type keytruda starting tumor agnostic indication trend cancer oncology,MRK,-0.0145369656383991
2020-06-18,newsars treatment ethical question appropriate continue clinical trial does include dexamethasone standard treatment gave remdesivir data safety monitoring board announce saving days hospitalization,MRK,0.6324838399887085
2020-06-18,outside coronavirus pandemic continuing watch development plans cancer drug keytruda keytruda easily important product facing rivalry bristol myers squibb opdivo,MRK,0.8490883111953735
2020-06-18,downtrend stochastic indicator stays oversold zone days view odds indicators stockmarket technicalanalysis money daytrading news,MRK,-1.0756648778915403
2020-06-18,mstarresearch analysts think appealing opportunity drug manufacturing combination wide,MRK,0.944139003753662
2020-06-18,shit sscncpespx,MRK,-1.0488128662109375
2020-06-18,analysts think appealing opportunity drug manufacturing combination wide lineup high margin drugs pipeline drugs ensure strong returns invested capital long term,MRK,0.979516625404358
2020-06-18,bought supply disruptions credit tightening bear play into hands pharma pushes capitalized strong pipeline small bios consolidate does need anymore than keytruda juggernaut want,MRK,0.9265068769454956
2020-06-18,inhibitor steglatrotm ertugliflozin meets primary endpoint vertis trial pati,MRK,-0.0773210600018501
2020-06-18,optimus maximus closed covered previously shorted profit corp stats,MRK,0.797437310218811
2020-06-18,first human back talked canadian infectious disease expert gary kobinger leading mind development ebola vaccine about lessons hurdles early clinical vaccine research,MRK,0.332467645406723
2020-06-18,animal health completes acquisition quantified,MRK,0.1973229795694351
2020-06-18,approves second biomarker based indication keytruda pembrolizumab regardless tumor type,MRK,0.1285424083471298
2020-06-18,billion debtoffering,MRK,-0.0694218575954437
2020-06-18,looking entry change recently taownpntdh,MRK,0.8974488973617554
2020-06-18,billion debt offering href,MRK,-0.0181706920266151
2020-06-18,billion debt offering,MRK,0.0273826867341995
2020-06-18,options maxpain chart open interest chart update optionstrading optionsflow stockmarket,MRK,0.4729502201080322
2020-06-18,sizable quote changes change recently taownpntdh,MRK,0.4213838577270508
2020-06-19,syinvesting ridgeback partnered progressing eidd into phase trials patients,MRK,-0.062692642211914
2020-06-19,ridgeback partnered progressing eidd into phase trials patients,MRK,-0.0308617427945137
2020-06-19,shooting through roof increase,MRK,0.9853668212890624
2020-06-19,,MRK,0.0299751423299312
2020-06-19,star appearances since close days later worst best days later worst best days later worst best,MRK,-0.8146243095397949
2020-06-19,optimus closed sold profit corp stats,MRK,0.6189471483230591
2020-06-19,long hope soon,MRK,0.9153352975845336
2020-06-19,receives consensus rating analysts,MRK,0.8996407985687256
2020-06-19,scorpionsinvest deal,MRK,0.4493983685970306
2020-06-19,yatesinvesting deal,MRK,0.8947217464447021
2020-06-19,ridgeback ready start tests covid drug fieonjhtso,MRK,0.2566014528274536
2020-06-19,completes acquisition themis,MRK,0.442325085401535
2020-06-19,withdraws keytruda application europe esophageal cancer,MRK,-0.9227982759475708
2020-06-19,latest news,MRK,0.3450494706630707
2020-06-19,looks rape case table,MRK,-1.055367350578308
2020-06-19,ready kick time option thinks,MRK,0.9831130504608154
2020-06-19,ring hopefully oral antiviral works back tour bballcrazy,MRK,0.4308922588825226
2020-06-19,completes themis coronavirus vaccine trials,MRK,0.9259803295135498
2020-06-19,completes acquisition themis,MRK,0.442325085401535
2020-06-19,completes themis coronavirus vaccine trials,MRK,0.9138413667678832
2020-06-19,completes themis coronavirus vaccine trials,MRK,0.9138413667678832
2020-06-19,latest news,MRK,0.3653012812137604
2020-06-19,directional bias report click details,MRK,-0.7779198884963989
2020-06-19,report click sell,MRK,0.2802823483943939
2020-06-19,completes acquisition themis,MRK,0.3244211077690124
2020-06-19,sees large drop short interest,MRK,-1.0776875019073486
2020-06-19,uptrend stochastic indicator leaves oversold zone view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9103636741638184
2020-06-19,sees large drop short interest,MRK,-1.072917342185974
2020-06-19,sees large drop short interest,MRK,-1.072917342185974
2020-06-19,sees large drop short interest,MRK,-1.072917342185974
2020-06-19,form prospectus rule filed,MRK,-0.0819078683853149
2020-06-19,physioo msollender heterotrimeric receptors associated taste function thus targeting lead significant taste effects seen gefapixant tolerability issue asset,MRK,-0.9532315731048584
2020-06-20,significant movement change recently,MRK,0.883901834487915
2020-06-20,pain maturity maxpain options ttvtzwfkup,MRK,-0.0561835765838623
2020-06-20,scanner identified friday beautiful reversal candles volume using only fibs,MRK,0.9866418838500975
2020-06-20,scanner identified friday beautiful reversal candles volume using only fibs identified high probability daytrade early,MRK,0.9765303134918212
2020-06-20,predatordiaries well reckon noise raising levels being sure thing medium term immunity being stretch goal trendy landing zones novel these days endpts biomarkers formerly known phii data,MRK,0.9065344333648682
2020-06-20,tickeron uptrend stochastic indicator leaves oversold zone view odds indicators,MRK,0.9415057897567748
2020-06-20,uptrend stochastic indicator leaves oversold zone view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9103636741638184
2020-06-20,substantial changes change recently,MRK,0.7925832271575928
2020-06-20,options power options maxpain chart open interest chart update optionstrading optionsflow optionstrade optiontrading stockmarket invest aylfehxfci,MRK,0.7075719833374023
2020-06-21,happy hold decent chunk oncology specialist,MRK,0.9666714668273926
2020-06-21,international biotechnology trust million position,MRK,0.1625210046768188
2020-06-21,reasonable changes change recently,MRK,0.9271970987319946
2020-06-21,happy hold decent chunk oncology specialist,MRK,0.9717330932617188
2020-06-21,surprised check dabble maybe change recently taownpntdh,MRK,-0.5558052062988281
2020-06-21,argi services boosts holdings,MRK,0.641494631767273
2020-06-21,advisors position,MRK,0.2043183743953704
2020-06-21,argi services boosts holdings exjoyoihdq,MRK,0.641494631767273
2020-06-21,inchartitrust joepunto wkalunji thank sharing upcoming news rarely news observed positive divergent action chart template holdingbags,MRK,0.949349045753479
2020-06-21,substantial changes change recently taownpntdh,MRK,0.7925832271575928
2020-06-21,tickeron uptrend stochastic indicator peaks leaves oversold zone view odds indicators,MRK,0.946029543876648
2020-06-21,uptrend stochastic indicator peaks leaves oversold zone view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9394015073776244
2020-06-21,ilmtraders long above targets short below targets ilmtraders dtilmtraders mark,MRK,0.6024507284164429
2020-06-21,long above targets short below targets ilmtraders dtilmtraders marketwatch,MRK,-0.2895959913730621
2020-06-21,change recently,MRK,0.8443390130996704
2020-06-22,voloridge management sells,MRK,-0.6920636892318726
2020-06-22,keytruda approved china second line treatment patients locally advanced metastatic,MRK,0.6372735500335693
2020-06-22,option alert calls sweep near earnings before open,MRK,0.6262693405151367
2020-06-22,option alert calls sweep near earnings before open,MRK,0.5415831804275513
2020-06-22,keytruda gets biomarker driven clearance regardless tumor type rahkbmboxz oncology pharma,MRK,-0.0038312822580337
2020-06-22,virus scale monday,MRK,-0.0603714771568775
2020-06-22,option alert puts earnings before open,MRK,0.1114545688033104
2020-06-22,announces investigational valent pneumococcal conjugate vaccine safety immunogenicity objectives initial phase studies adults,MRK,0.0936173349618911
2020-06-22,keytruda approved china indications across different cancer types,MRK,-0.0331970602273941
2020-06-22,wins keytruda china approval analyst applauds first mover advantage,MRK,0.8287279605865479
2020-06-22,tickeron uptrend stochastic indicator leaves oversold zone view odds indicators,MRK,0.9415057897567748
2020-06-22,uptrend stochastic indicator leaves oversold zone view odds indicators stockmarket technicalanalysis money daytrading news jfyoaepyks,MRK,0.9103636741638184
2020-06-22,moot,MRK,0.0335039347410202
2020-06-22,read latest pneumococcal disease news isppd qotjpxumps,MRK,0.1625703275203704
2020-06-22,announces investigational valent pneumococcal conjugate vaccine safety,MRK,0.0364885628223419
2020-06-22,beating yield accelerating dividend growth potential undervalued rare opportunity above average business below average jasonfieber latest udgsow pick,MRK,0.9981409311294556
2020-06-22,announces investigational valent pneumococcal conjugate vaccine safety immunogenicity objectives initial phase studies adults,MRK,0.0618467442691326
2020-06-22,keytruda approved china second line treatment patients locally advanced metastatic,MRK,0.6284403800964355
2020-06-22,keytruda pembrolizumab approved china second line treatment patients locally advanced metastatic esophageal squamous cell carcinoma whose tumors express,MRK,0.3075749278068542
2020-06-22,pneumonia vaccine successful late stage studies,MRK,0.7273392677307129
2020-06-22,learn about newest update esophagealcancer cwvgpbkcmq,MRK,0.1624110490083694
2020-06-22,keytruda pembrolizumab approved china second line treatment patients locally xqcbkkohht,MRK,0.2990288734436035
2020-06-22,announces investigational valent pneumococcal conjugate vaccine safety,MRK,0.0412325672805309
2020-06-22,marketcurrents pneumonia vaccine successful late stage studies,MRK,0.9403239488601683
2020-06-22,pneumonia vaccine successful late stage studies,MRK,0.958843231201172
2020-06-22,announces investigational valent pneumococcal conjugate vaccine safety immunogenicity objectives initial phase studies adults,MRK,0.1144994720816612
2020-06-22,safety immunogenicity objectives phase studies,MRK,0.0889151245355606
2020-06-22,read latest pneumococcal disease news isppd qotjpxumps,MRK,0.119779996573925
2020-06-22,keytruda china line esophageal cancer ydxcroqbah,MRK,0.6576042175292969
2020-06-22,marketcurrents keytruda china line esophageal cancer,MRK,0.735535740852356
2020-06-22,keytruda china line esophageal cancer,MRK,0.6576042175292969
2020-06-22,learn about newest update esophagealcancer cwvgpbkcmq,MRK,0.1455101519823074
2020-06-22,keytruda approved china treatment escc,MRK,0.651542067527771
2020-06-22,keytruda pembrolizumab approved china second line treatment patients locally advanced metastatic esophageal squamous cell carcinoma whose tumors express,MRK,0.2427781969308853
2020-06-22,keytruda approved china second line treatment patients locally advanced metastatic esophageal squamous cell carcinoma whose tumors express,MRK,0.5363994836807251
2020-06-22,bear burger medium rare mushroom swiss please change recently,MRK,0.6072205305099487
2020-06-22,,MRK,0.014295183122158
2020-06-23,jason fieber tipping biggest pharma holding undervalued along healthcare pharma dividend practically prints money sale youtube,MRK,0.9615921974182128
2020-06-23,implied volatility straddle implies move earnings,MRK,-1.0613479614257812
2020-06-23,sorry date respect,MRK,-1.0542826652526855
2020-06-23,shot interest what mess,MRK,-0.8856519460678101
2020-06-23,carret asset management trims stake onhnuhknof,MRK,0.0688895136117935
2020-06-23,cryptoparadyme calls active,MRK,0.8520083427429199
2020-06-23,calls active,MRK,0.7616342306137085
2020-06-23,files form,MRK,-0.1102470457553863
2020-06-23,donnayoungdc julie gerberding vaccines need higher safety using,MRK,0.7883201837539673
2020-06-23,think appreciate ridgeback oral antiviral candidate eidd covid which blockbuster potential successful covid patients take oral after initial diagnosis reduce disease severity risk reiterate rating,MRK,0.9810842275619508
2020-06-23,uptick party,MRK,0.996381402015686
2020-06-23,pattymurray build public confidence vaccines gerberding transparency safety assessments involves acip scientific organizations safety monitored thenamedicine,MRK,0.1533182710409164
2020-06-23,gerberding large vaccines manufacturers almost capacity need build done best public private partnership platform approach partnership model works best remove incentives pharma biotech innovate,MRK,0.9774839878082277
2020-06-23,optstrategist update entered back january discussed were stopped winning puts,MRK,0.6145092248916626
2020-06-23,gerberding sustained national leadership level national security council critical sustained long term budgetary ending cycle complacency crisis needs function apolitical environment pandemic,MRK,0.8308205604553223
2020-06-23,optstrategist gapped favor earnings tighten stop short position high,MRK,-1.0722547769546509
2020-06-23,julie gerberding vaccines need higher safety using sacrifice safety sake speed people need trust vaccine safe pandemic,MRK,0.9813687801361084
2020-06-23,former julie gerberding know virus incredibly transmissible causes great harm serious morbidity mortality know continue spread months come nowhere near mitigation phase crisis pandemic,MRK,0.8110659122467041
2020-06-23,donnayoungdc former bush admin officials govmikeleavitt julie gerberding former leader bill,MRK,-0.0144324451684951
2020-06-23,theflynews covid antiviral candidate underappreciated says morgan stanley hokoeszyyp,MRK,0.6160190105438232
2020-06-23,senalexander subject witnesses bfrist govmikeleavitt julie gerberding michiganhhs drkhaldun pandemic,MRK,-0.0486955866217613
2020-06-23,wait collab announcement,MRK,0.5264389514923096
2020-06-23,covid antiviral candidate underappreciated says morgan stanley hokoeszyyp,MRK,0.6786994934082031
2020-06-23,covid antiviral candidate underappreciated says morgan stanley,MRK,0.8046301603317261
2020-06-23,about face,MRK,0.4239530265331268
2020-06-23,expected quarter,MRK,0.1335571259260177
2020-06-23,zacks analysts anticipate earnings,MRK,0.3153860867023468
2020-06-23,expected quarter,MRK,0.1335571259260177
2020-06-23,expected quarter xuvvmlfxkr,MRK,0.1979430168867111
2020-06-23,former bush admin officials govmikeleavitt julie gerberding former leader billfrist gophelp helpcmtedems talking about lessons learned pandemic planning pandemic,MRK,0.000885471701622
2020-06-23,johnwelshtrades news around corner potential collab,MRK,0.1596170961856842
2020-06-23,uptrend stochastic indicator recovers oversold zone view odds indicators stockmarket technicalanalysis money daytrading news mmvlnohndx,MRK,0.9553284645080566
2020-06-23,bioinvent enroll first patient solid tumor combo trial,MRK,0.8569440841674805
2020-06-23,bioinvent enrolls first patient phase trial combination keytruda,MRK,0.1478231251239776
2020-06-23,bioinvent enrolls first patient phase trial combination keytruda treatment patients solid tumors ttrzoxgdqo,MRK,0.923636555671692
2020-06-23,keytruda pembrolizumab approved china second line treatment patients locally advanced metastatic esophagealsquamouscellcarcinoma whose tumors express,MRK,0.2234597951173782
2020-06-23,advances along broad phiii front aimed carving selling vaccine franchise ambush wait,MRK,0.1094306632876396
2020-06-23,major changes,MRK,0.3438725471496582
2020-06-23,brokerages target kdwwvgcpvp,MRK,0.1006430014967918
2020-06-24,announces approved keytruda recurrent metastatic cutaneous squamous cell lleujynscw,MRK,0.0206799432635307
2020-06-24,keytruda treatment resistant type skin cancer,MRK,-0.0767517685890197
2020-06-24,approves keytruda pembrolizumab treatment patients recurrent metastatic,MRK,0.1434925943613052
2020-06-24,announcing latest oncology approval advanced cutaneous squamous cell carcinoma cscc skincancer,MRK,0.7031922340393066
2020-06-24,approves keytruda treatment patients recurrent metastatic cutaneous squamous cell carcinoma enwvpqvoul,MRK,-0.0615085363388061
2020-06-24,keytruda approved cscc curable surgery radiation,MRK,0.2744728028774261
2020-06-24,files form financial statements exhibits events,MRK,-0.1056424528360366
2020-06-24,form press news current report recently filed,MRK,-0.0137268528342247
2020-06-24,keytruda treatment resistant type skin cancer gtfeoichyg,MRK,-0.0529520809650421
2020-06-24,bayer billion settle bulk roundup weedkiller cancer lawsuits,MRK,-0.0591161176562309
2020-06-24,excellent deal access neuro disease drugs pens million yumanity pact nabbing neuro hopefuls process neurodegenerativedisease neurodegenerative,MRK,1.0044585466384888
2020-06-24,added hold portfolio looks holding support undervalued holding these years,MRK,0.9571349620819092
2020-06-24,done careful,MRK,-1.0019097328186035
2020-06-24,biopharmadive hasn invested neuroscience since alzheimer drug plans unraveled deals past,MRK,-0.1241099536418914
2020-06-24,done careful,MRK,-1.0270806550979614
2020-06-24,benthefidler strikes another neuroscience deal tapping yumanity brain drugs skhkokwamd yumanitytx,MRK,-0.1230956614017486
2020-06-24,hasn invested neuroscience since alzheimer drug plans unraveled deals past however help keep options open,MRK,0.5085881948471069
2020-06-24,donnayoungdc gerberding another opportunity improvement terms accountable leadership stockpile moved,MRK,0.9699898958206176
2020-06-24,donnayoungdc gerberding clear asset operate standalone entity prepared meet,MRK,-0.103785440325737
2020-06-24,gerberding strategic national stockpile budget process needs improvement impossible budget clarity what supposed accomplish often tail wags pandemic,MRK,0.7610265016555786
2020-06-24,gerberding another opportunity improvement terms accountable leadership stockpile moved fema involved current deployment consistent accountable leadership clarity delivery,MRK,0.9280195236206056
2020-06-24,gerberding clear asset operate standalone entity prepared meet needs augment states health care settings doing already inconsistency ping pong approach what procurement decisions,MRK,0.1242569014430046
2020-06-24,senate hsgac hearing former julie gerberding debates inconsistencies whether conceived something deployed locally national crisis need meet entire country,MRK,-0.1521001458168029
2020-06-24,these upgrades good,MRK,0.9738218784332277
2020-06-24,fwpharma yumanity partner neurodegenerative disease drug development,MRK,-0.0495693758130073
2020-06-24,underscores commitment data analyses presented aids,MRK,0.0777647346258163
2020-06-24,yumanity partner neurodegenerative disease drug development,MRK,-0.0317745432257652
2020-06-24,uptrend stochastic indicator peaks leaves oversold zone view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9394015073776244
2020-06-24,adamfeuerstein yumanity therapeutics strike deal aimed developing medicines neurodegenerative disease,MRK,0.1633602082729339
2020-06-24,yumanity therapeutics strike deal aimed developing medicines neurodegenerative disease,MRK,0.1728568375110626
2020-06-24,underscores commitment data analyses presented aids virtual,MRK,0.086992472410202
2020-06-24,underscores commitment data analyses presented aids virtual,MRK,0.0942564085125923
2020-06-24,underscores commitment data analyses presented aids virtual ygdetuapem,MRK,0.1016530245542526
2020-06-24,committed helping address unmet needs community along latest data during aids virtual conference,MRK,0.4970289170742035
2020-06-24,rating reaffirmed mizuho,MRK,0.883885383605957
2020-06-24,rating reaffirmed mizuho,MRK,0.883885383605957
2020-06-24,rating reaffirmed morgan stanley,MRK,0.8767925500869751
2020-06-24,morgan stanley reaffirms rating,MRK,0.8714958429336548
2020-06-24,rating reaffirmed morgan stanley,MRK,0.8767925500869751
2020-06-24,rating reaffirmed mizuho,MRK,0.883885383605957
2020-06-24,rating reaffirmed mizuho,MRK,0.883885383605957
2020-06-24,morgan stanley reaffirms rating,MRK,0.8824141025543213
2020-06-24,lake point wealth management increases holdings,MRK,0.900913953781128
2020-06-24,integrated wealth concepts raises position,MRK,0.7689089775085449
2020-06-25,wasn expecting honest hype finishes happy bought late regret selling hopefully collab,MRK,0.9454632997512816
2020-06-25,company profile fundamental technical analysis score update score score stockmarket invest knebzgedas,MRK,0.0461053028702735
2020-06-25,great stuff keep mind wants dominate often involves working competitors always though runor sell news,MRK,0.9898818731307985
2020-06-25,advisors increases holdings,MRK,0.8771039247512817
2020-06-25,little action speak,MRK,-0.5381656885147095
2020-06-25,whattthefleck merger gunna take motherland phil,MRK,0.2984726130962372
2020-06-25,idea support resistance first test target,MRK,0.5887761116027832
2020-06-25,chitraders reports approves keytruda treatment patients recurrent metastatic cutaneous squamous cell carcinoma,MRK,0.056876853108406
2020-06-25,openoutcrier keytruda treatment resistant type skin cancer,MRK,-0.8766944408416748
2020-06-25,keytruda treatment resistant type skin cancer,MRK,-0.7876158952713013
2020-06-25,reports approves keytruda treatment patients recurrent metastatic cutaneous squamous cell carcinoma curable surgery radiation,MRK,-0.0643775463104248
2020-06-25,stantradingman confident guys,MRK,0.8302218914031982
2020-06-25,tickeron uptrend stochastic indicator recovers oversold zone view odds indicators srbh,MRK,0.9635707139968872
2020-06-25,uptrend stochastic indicator recovers oversold zone view odds indicators srbhbqrohy stockmarket technicalanalysis money daytrading news,MRK,0.9553284645080566
2020-06-25,approves keytruda pembrolizumab treatment patients recurrent metastatic cutaneoussquamouscellcarcinoma cscc curable surgery radiation,MRK,-0.2124303430318832
2020-06-25,zacks analysts expect announce sales billion,MRK,0.0880366861820221
2020-06-25,billion sales expected quarter bqpimmqglb,MRK,0.2592760026454925
2020-06-25,zacks analysts expect announce sales billion,MRK,0.0880366861820221
2020-06-25,zacks analysts expect announce sales billion,MRK,0.0880366861820221
2020-06-25,rating reiterated morgan stanley,MRK,0.2557893991470337
2020-06-25,rating reiterated morgan stanley,MRK,0.2557893991470337
2020-06-25,rating reiterated morgan stanley,MRK,0.2557893991470337
2020-06-25,rating reiterated morgan stanley,MRK,0.2557893991470337
2020-06-25,approves keytruda treatment patients recurrent metastatic cutaneous squamous cell carcinoma jmankuzphb,MRK,-0.0008810609579086
2020-06-25,burned alzheimer failures cautious turns startup biotech preclinical neuro programs,MRK,-1.0419259071350098
2020-06-25,interesting closed billion public offering,MRK,0.930832862854004
2020-06-25,keytruda treatment resistant type skin cancer ntnekdtqzv,MRK,-0.0055097453296184
2020-06-25,given average recommendation brokerages,MRK,0.8635251522064209
2020-06-25,interesting closed billion public offering,MRK,0.9336049556732178
2020-06-25,keytruda treatment resistant type skin cancer ntnekdtqzv,MRK,-0.0529520809650421
2020-06-25,yumanity entered collab focused disease modifying therapies neurodegenerative diseases gained exclusive rights preclinical pipeline programs yumanity received undisclosed milestones csizadsruj,MRK,0.7152880430221558
2020-06-26,luubearrr chrisrandone collab announcement happens seen take york minute help israel,MRK,0.7775903940200806
2020-06-26,what looks sell,MRK,-1.064060091972351
2020-06-26,company profile fundamental technical analysis score update score score stockmarket invest,MRK,0.0461053028702735
2020-06-26,growthdividend bought vaccines children manufacturer these small operations every across,MRK,0.1092410907149314
2020-06-26,bought vaccines children manufacturer these small operations every across world make them high quality companies stick around dividends,MRK,0.9498111009597778
2020-06-26,changing lives,MRK,0.5376825332641602
2020-06-26,what does look monday,MRK,-0.0663584768772125
2020-06-26,what does look monday,MRK,-0.0573767088353633
2020-06-26,moderndfinance same think tank,MRK,0.7184877395629883
2020-06-26,biopharmadive results late stage studies experimental pneumococcal conjugate vaccine help support,MRK,0.3467922508716583
2020-06-26,pens yumanity pact nabbing neuro hopefuls process collaboration beef neurology pipeline after company behind alzheimer program,MRK,-0.0607805699110031
2020-06-26,uptrend stochastic indicator peaks leaves oversold zone view odds indicators vzpcowcjmc stockmarket technicalanalysis money daytrading news pszzwniuta,MRK,0.9394015073776244
2020-06-26,earns rating mizuho illewxqcfs,MRK,0.8761838674545288
2020-06-26,highly overlooked ktov,MRK,-0.8545076847076416
2020-06-26,earns rating mizuho,MRK,0.9276423454284668
2020-06-26,receives rating morgan stanley uhribuyjso,MRK,0.8412171602249146
2020-06-26,receives rating morgan stanley,MRK,0.871347188949585
2020-06-26,straddle implies move pdufa,MRK,0.3429857492446899
2020-06-26,dividend practically prints money,MRK,0.0864992439746856
2020-06-26,heavyweight keytruda cancer niche triggering title fight street brawlers regeneron,MRK,-0.7618710994720459
2020-06-26,stockdweebs entirely play longs expect collab announcement comes long hope jumps fades,MRK,0.7907160520553589
2020-06-26,bought baby dividendinvesting,MRK,0.9485187530517578
2020-06-27,daytradelsu keytruda piece puzzle willing shell royalties every years buyout almost easier,MRK,0.2131499052047729
2020-06-27,catsgamecapital really depends does because used than atopic derm well prove pivotal clearly highest upside drugs valued between successful gobble,MRK,0.966341495513916
2020-06-27,calls alerted peak after alert progress,MRK,0.8915084600448608
2020-06-27,puts alerted peak after alert progress tpkywjpxsj,MRK,0.8529850244522095
2020-06-27,peak profit expired option alerts wgntwmzsdn,MRK,0.6875190734863281
2020-06-27,calls option volume volume,MRK,0.8937970399856567
2020-06-27,performance algo based option alerts,MRK,0.3085912764072418
2020-06-27,months option alerts peaked above after were triggered algo,MRK,0.9204837083816528
2020-06-27,view historical options performance shiwnqbxuu,MRK,0.0985150188207626
2020-06-27,upcoming event june pdufa options expiring july cover event implied move fodvjkcwwh,MRK,0.2227286547422409
2020-06-27,soothsayaer thorougbred ready needs jockey into winning circle,MRK,0.891951322555542
2020-06-27,enters downtrend because momentum indicator dropped below level june view odds indicators stockmarket technicalanalysis money daytrading news syjpbuybyk,MRK,-1.073905110359192
2020-06-27,stop alert discord,MRK,-1.031480312347412
2020-06-27,straddle implies move pdufa,MRK,0.3129135966300964
2020-06-28,open interest maturity high high call putcallratio maxpain options crsfgmfonn,MRK,0.91763174533844
2020-06-28,chrisrandone imagine,MRK,0.0205517970025539
2020-06-28,directional bias report click details,MRK,-0.7779198884963989
2020-06-28,report watdlwdecf click sell,MRK,0.2802823483943939
2020-06-28,mykonmusic collabin buyout announce within days spending hear logic versus collab royalties,MRK,0.7100658416748047
2020-06-28,quailtrading understanding thought behind absorb ticker thus driving value ticker double check theory,MRK,0.9489178657531738
2020-06-28,another pharma name looks rough macd divergences measured move breakdown wrong,MRK,-1.0812922716140747
2020-06-28,kiyoshistocksup rednecrenegade sounds offering notes coming years,MRK,0.1279136091470718
2020-06-28,kiyoshistocksup does announce what doing within days wait long want basically what asking obligated report what doing money within days,MRK,0.0252627506852149
2020-06-28,expected announce earnings,MRK,0.3408951163291931
2020-06-28,expected announce sales billion,MRK,0.0937201976776123
2020-06-28,expected announce earnings,MRK,0.3408951163291931
2020-06-28,start saying know repeating information announced spendi,MRK,0.168239414691925
2020-06-28,saltypendejos mrzackmorris because hasn actually announced done clues lead collab guarantee pretty likely,MRK,0.6030526161193848
2020-06-28,crferrie anything happen filing sure does make things look promising,MRK,0.9804538488388062
2020-06-28,thetweetofrob mcsteamyyyyyyy than already known about stuff correct,MRK,0.0264026969671249
2020-06-28,thetweetofrob mcsteamyyyyyyy already work maybe buyout knows,MRK,0.9620532989501952
2020-06-28,thetweetofrob mcsteamyyyyyyy part about form divide announce spending approved test neck cancer,MRK,-0.5050922632217407
2020-06-28,start saying know repeating information announced spending days companies usually announce monday increase ketruyda sales mention sell twice,MRK,-0.9753296375274658
2020-06-28,enters downtrend because momentum indicator dropped below level june view odds indicators stockmarket technicalanalysis money daytrading news,MRK,-1.073905110359192
2020-06-28,bostonianpsycho collaborated bought companies since anything them filing,MRK,0.7758340835571289
2020-06-29,keytruda first line treatment patients dmmr metastatic colorectal cancer colorectalcancer cancer,MRK,0.0941987037658691
2020-06-29,woahhhhhhh wording look familiar tonight breadcrumbs people,MRK,0.1546850800514221
2020-06-29,woahhhhhhh wording look familiar tonight breadcrumbs people,MRK,0.1326265931129455
2020-06-29,iamjohnchang,MRK,0.9571309089660645
2020-06-29,learn about latest approval colorectalcancer vqimaausra,MRK,0.4239733815193176
2020-06-29,briefingcom approves keytruda first line treatment patients dmmr metastatic colorectal,MRK,0.2206832468509674
2020-06-29,approves keytruda first line treatment patients dmmr metastatic colorectal,MRK,0.1769594550132751
2020-06-29,another milestone precision medicine approves first line immunotherapy patients dmmr metastatic colorectal cancer hgqujokboh,MRK,0.2776128947734833
2020-06-29,iamjohnchang keytruda approved head neck learn colorec,MRK,0.9067469835281372
2020-06-29,approves keytruda pembrolizumab first line treatment patients unresectable,MRK,0.2080762982368469
2020-06-29,anothert,MRK,0.9690687656402588
2020-06-29,learn about latest approval colorectalcancer vqimaausra,MRK,0.4754774868488312
2020-06-29,keytruda highly mutating forms colorectal cancer,MRK,-0.0476337224245071
2020-06-29,huge buys into close hmmm,MRK,0.9824858903884888
2020-06-29,keytruda highly mutating forms colorectal cancer,MRK,-0.533158540725708
2020-06-29,keytruda highly mutating forms colorectal cancer,MRK,-0.0476337224245071
2020-06-29,looking strong into close,MRK,0.965298056602478
2020-06-29,hating chillin anything profits finna make rich,MRK,0.8237749338150024
2020-06-29,stoolpresidente filled form planning spend somethings coming,MRK,0.1770362555980682
2020-06-29,approves keytruda first line therapy certain colorectal cancers,MRK,0.0386767014861106
2020-06-29,shortly after received face book family florida freind driving motorcycle mobile alabama received broken back trying find driver,MRK,-0.7047772407531738
2020-06-29,every texting while driving sonner later catch someone love lose life,MRK,-0.061424471437931
2020-06-29,what folks playing games lives lives families risk stupit,MRK,-0.943629503250122
2020-06-29,based what seen approval timing events holding company announce lets roll,MRK,0.7833259105682373
2020-06-29,monday,MRK,0.2911636233329773
2020-06-29,optimus maximus shorted opened corp chance loss hold stats,MRK,0.8739778995513916
2020-06-29,short progress looks promising,MRK,0.9326896667480468
2020-06-29,tickeron uptrend stochastic indicator peaks leaves oversold zone view odds indicators,MRK,0.946029543876648
2020-06-29,uptrend stochastic indicator peaks leaves oversold zone view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9394015073776244
2020-06-30,roll blazes through segment biomarker trail,MRK,0.0913695469498634
2020-06-30,success rate cancer drug rises success patients reject drug pump,MRK,0.9141088724136353
2020-06-30,bigshotcos well considering opposed take swap,MRK,0.5941741466522217
2020-06-30,flying,MRK,0.9474977254867554
2020-06-30,keytruda approved early treatment colorectal cancer patients genetic mutations mhexecutive,MRK,0.5520312786102295
2020-06-30,profits sooooooo profits,MRK,0.9506072998046876
2020-06-30,offering great long term hold comes partnership distribute approved medication want weak sellers trickle volume spikes,MRK,0.800034761428833
2020-06-30,cancer immunotherapy drug gets expansion biomarker based labeling writes biotechvisigoth medcitynews cuwtrplhjw cancer immunotherapy,MRK,0.5525721311569214
2020-06-30,whether announcement done later what planning scratch refutes open listening,MRK,0.2366696000099182
2020-06-30,only thing doing locking rates future people doing home buys rates,MRK,-0.9947912693023682
2020-06-30,deal making activity kept pace weeks ended june takedapharma among those striking licensing deals according spgmarketintel data,MRK,0.0682353004813194
2020-06-30,already disclosed,MRK,0.0440829619765281
2020-06-30,clue hearing through rumor mill billiion hasn disclosed supposed disclose happen before does wait,MRK,0.298153668642044
2020-06-30,good fundamental analysis score score check various indicators value score chart roic gross margin ebitda stockmarket,MRK,0.975943922996521
2020-06-30,tickeron uptrend jump because broke lower bollinger band june view odds,MRK,0.9267996549606324
2020-06-30,uptrend jump because broke lower bollinger band june view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9398188591003418
2020-06-30,optimus maximus shorted opened corp chance loss hold stats,MRK,0.8794807195663452
2020-06-30,eboncology icymi keytruda gets line colorectal cancer patients dmmr,MRK,0.7940812110900879
2020-06-30,aproval inprovment keytruda stand along without chemotherapy deal chemo tars revalation,MRK,-0.9399795532226562
2020-06-30,openoutcrier announces approves keytruda first line treatment patients unresectable,MRK,0.2492494583129882
2020-06-30,announces approves keytruda first line treatment patients unresectable metastatic dmmr colorectal cancer,MRK,0.1773964762687683
2020-06-30,twice pill change course pandemic interview former biotech brain capital turned drug developer recently partnered,MRK,-0.0935186147689819
2020-06-30,icymi keytruda gets line colorectal cancer patients dmmr,MRK,0.8739172220230103
2020-06-30,during killing mention anything about collab,MRK,-1.0528253316879272
2020-06-30,approves keytruda pembrolizumab first line treatment patients unresectable metastatic msih dmmr colorectalcancer,MRK,0.5045932531356812
2020-06-30,approves keytruda first line treatment patients unresectable metastatic dmmr colorectal cancer qrsgifdotx,MRK,0.1058143228292465
2020-06-30,sorry misunderstood friend million dollar question trying research what time usually especially difficult because chance collab american company does change things,MRK,-1.0592399835586548
2020-06-30,actually deal give equivalent value depending buyout,MRK,0.9442451000213624
2020-06-30,iamjohnchang abahfungoulo announce collaboration table acquisition house happening,MRK,-0.2398882955312729
2020-06-30,approves first first line immunotherapy defining standard care,MRK,0.321711927652359
2020-07-01,ridgeback biotherapeutics announce closing collaboration licensing transaction,MRK,-0.7396132946014404
2020-07-01,latest company update ngskhepwgf,MRK,0.2676947712898254
2020-07-01,ridgeback close collaboration licensing transaction ridgebackbio,MRK,-0.5259056091308594
2020-07-01,what means buyout seems likely time collab than likely news come before meeting sure seems issac charge forward trials long haul,MRK,0.9153108596801758
2020-07-01,ridgeback announce closing collaboration licensing transaction,MRK,-0.3777269423007965
2020-07-01,think mighty active social media trolling announced whole different collaboration often collaboration being thrown around,MRK,0.0298542790114879
2020-07-01,latest company update ngskhepwgf,MRK,0.2764926254749298
2020-07-01,ridgeback biotherapeutics close collaboration licensing deal,MRK,-0.2207518368959427
2020-07-01,rising volume appearances since close days later worst best days later worst best days later worst best,MRK,-0.1750400215387344
2020-07-01,optimus maximus closed covered previously shorted loss corp stats,MRK,-1.0765010118484497
2020-07-01,interested saving lives keytruda elements large stables drugs diverse pharma arms diversity,MRK,1.0049163103103638
2020-07-01,ladebackk cancer drug works collab waiting easily worth,MRK,0.819710373878479
2020-07-01,vallage people moving takes hole village move,MRK,0.4573453366756439
2020-07-01,main asset people team history shows succeeded everything trend succees fail time,MRK,0.8521443605422974
2020-07-01,good volume holding target,MRK,0.9549213647842408
2020-07-01,chart shows june open high close show difference give breath change what look forward little short term history gltall,MRK,0.677413821220398
2020-07-01,vallage people moving takes hole village move,MRK,0.4356981813907623
2020-07-01,short options thay moved guestion strick,MRK,-1.0035167932510376
2020-07-01,rose above,MRK,0.9150351285934448
2020-07-01,perhaps poke ahole upward move hope reads showing indication possitive studys factors moot deep wide,MRK,0.8418877124786377
2020-07-01,,MRK,0.9162977933883668
2020-07-01,humpday hold good blue ribben company volitillity crazy glta,MRK,-1.0379375219345093
2020-07-01,optimus maximus closed covered previously shorted loss corp stats,MRK,-1.0749027729034424
2020-07-01,hold second quarter sales earnings conference call july,MRK,-0.0182328186929225
2020-07-01,join earnings conference call july,MRK,0.0131795704364776
2020-07-01,join earnings conference call july,MRK,0.0314072221517562
2020-07-01,date approaching,MRK,-0.0186138078570365
2020-07-01,hold second quarter sales earnings conference call july,MRK,0.0369831509888172
2020-07-01,enters uptrend momentum indicator exceeded level june view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8999468088150024
2020-07-01,gets keytruda therapy metastatic colorectal cancer patients,MRK,0.0262886211276054
2020-07-01,briefing wednesday july,MRK,0.0051066912710666
2020-07-01,expected earnings,MRK,0.3585638999938965
2020-07-01,billion sales expected quarter,MRK,0.2592760026454925
2020-07-01,billion sales expected quarter,MRK,0.2592760026454925
2020-07-01,stonksgobink sorry confused approval announcement regards public offering closed announcement anything assume partnership,MRK,-1.0668928623199463
2020-07-02,taking long figure what want figure what company collab outcome lily study make alienated nhqntmmyze,MRK,-1.0278230905532837
2020-07-02,animal health completes acquisition rights sentinel brand combination parasiticides companion animals khdgeiydaf,MRK,0.2245917618274688
2020-07-02,good,MRK,0.9420188665390016
2020-07-02,similar efficacy taste alterations,MRK,0.537390947341919
2020-07-02,flyingstocksman consistent trend decade hugging cloud closely above,MRK,0.9674930572509766
2020-07-02,planning,MRK,0.2263628393411636
2020-07-02,ratings,MRK,0.0643954575061798
2020-07-02,consistent trend decade hugging cloud closely above cloud fintwit wallstreet,MRK,0.9721795320510864
2020-07-02,fast track king real great mask please,MRK,0.9740757942199708
2020-07-02,fast aprovals want load aprovel happen time fram charge,MRK,0.826033353805542
2020-07-02,main tips buys pebb fund polar capital global insurance unit trust dyor,MRK,0.8726272583007812
2020-07-02,acquired wendell peter director reported form filed,MRK,0.1834173798561096
2020-07-02,keep,MRK,0.7969975471496582
2020-07-02,lramseu look pharma them being acquired future dddd,MRK,0.174631118774414
2020-07-02,look pharma them being acquired future dddd,MRK,0.354990005493164
2020-07-02,wayneridgeback happy join forces vanquish sars great partner,MRK,0.9710931777954102
2020-07-02,insider filing director christine seidman,MRK,0.0535541772842407
2020-07-02,acquired seidman christine director reported form filed,MRK,0.2091498374938964
2020-07-02,insider filing director mary ellen,MRK,0.0507217086851596
2020-07-02,acquired mary ellen director reported form filed,MRK,0.1773179918527603
2020-07-02,happy join forces vanquish sars great partner,MRK,0.9769012928009032
2020-07-02,village gather,MRK,0.5128839015960693
2020-07-02,derivatives show,MRK,0.2529471814632416
2020-07-02,thinking granted nice,MRK,0.9756523370742798
2020-07-02,click read latest merckah news,MRK,0.34400075674057
2020-07-02,uptrend stochastic indicator recovers oversold zone view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9553284645080566
2020-07-02,animal health completes acquisition rights sentinel brand clkfznrumo,MRK,0.1844944655895233
2020-07-02,dddd holding back think exciting reply fast tracking approval combo treat keytruda skipping phase trials main stream application near future transform revenue,MRK,0.7940812110900879
2020-07-02,animal health completes acquisition rights sentinel brand combination parasiticides,MRK,0.1927799135446548
2020-07-02,virbac completes divestment rights sentinel brands animal health,MRK,-0.1138412505388259
2020-07-02,straddle implies move aids conference aids virtual,MRK,0.3167980909347534
2020-07-02,racist former raymond gilmartin murdered thousands black people vioxx stepped position into hiding time visit blacklivesmatter blacklivesmattteruk,MRK,-0.2049944251775741
2020-07-03,kiyoshistocksup does give combining keytruda,MRK,0.5855064392089844
2020-07-03,recent technical alerts crossed above plus alerts,MRK,0.7677408456802368
2020-07-03,uptrend ascend result having broken lower bollinger band june view odds indicators stockmarket technicalanalysis money daytrading news ogmydtpfnt,MRK,0.8645811080932617
2020-07-03,cantor fitzgerald sets earnings estimates,MRK,0.0304435715079307
2020-07-03,research analysts offer predictions earnings,MRK,0.046193778514862
2020-07-03,insider filing director peter wendell,MRK,0.0535744428634643
2020-07-04,high range option expiration putcallratio maxpain options,MRK,0.9654250144958496
2020-07-04,ridgeback announce closing collaboration licensing transaction,MRK,-0.7134097814559937
2020-07-04,upcoming event july aids conference aids virtual options expiring july cover event implied move,MRK,0.2267520874738693
2020-07-04,cacti asset management sells,MRK,-0.6375555992126465
2020-07-05,uptrend expected rise breaks lower bollinger band june view odds indicators stockmarket technicalanalysis money daytrading news flubcuvcto,MRK,0.9448394775390624
2020-07-05,earnings cantor fitzgerald forecasts,MRK,0.3258922398090362
2020-07-05,equities analysts issue forecasts earnings,MRK,0.0212747380137443
2020-07-05,symbol logo mark trademark filing sharp dohme corp,MRK,0.0148528292775154
2020-07-06,ratings,MRK,0.0643954575061798
2020-07-06,innovating remains crucial work learn about latest data released,MRK,0.388184130191803
2020-07-06,save alot lives hope cancer areas,MRK,0.8699774742126465
2020-07-06,approvals fact moat monetize make,MRK,0.94249165058136
2020-07-06,mizuho analyst target,MRK,-0.0147067382931709
2020-07-06,removes competition overhang mizuho securities,MRK,-0.205076202750206
2020-07-06,compounding sector increase history repeats self,MRK,0.7090959548950195
2020-07-06,dividend coming,MRK,-0.1413267105817794
2020-07-06,need brake,MRK,0.0313511602580547
2020-07-06,back about time,MRK,0.8318237066268921
2020-07-06,reports analyses showing additional safety efficacy data investigational islatravir,MRK,0.1268491894006729
2020-07-06,announces analyses showing additional safety efficacy data investigational islatravir combination doravirine adults infection,MRK,0.1590015441179275
2020-07-06,matthewherper bellus health suffers setback clinical trial failure chronic cough drug adamfeuerstein writes bayer,MRK,-0.876140832901001
2020-07-06,sbwcws announces analyses islatravir trial,MRK,0.1792096346616745
2020-07-06,announces analyses showing additional safety efficacy data investigational islatravir,MRK,0.1491259485483169
2020-07-06,announces analyses showing additional safety efficacy data investigational islatravir combination doravirine adults infection,MRK,0.1892591416835785
2020-07-06,bellus health suffers setback clinical trial failure chronic cough drug adamfeuerstein writes bayer shionogi benefit,MRK,-0.4335496127605438
2020-07-06,announces analyses islatravir trial,MRK,0.1761310845613479
2020-07-06,innovating remains crucial work learn about latest data released,MRK,0.381676435470581
2020-07-06,announces analyses showing additional safety efficacy data investigational islatravir combinati,MRK,0.2347697913646698
2020-07-06,announces analyses showing additional safety efficacy data investigational islatravir combination doravirine,MRK,0.2687781453132629
2020-07-06,nyse target nyse medical,MRK,0.1021753102540969
2020-07-06,uptrend jump because broke lower bollinger band june view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9398188591003418
2020-07-07,perhaps brackout foward,MRK,-0.0759185478091239
2020-07-07,stockonomist physiomics physiomics work being cited biggest global pharma companies,MRK,0.0590898022055625
2020-07-07,great flying weather ride hold enjoy trip,MRK,0.9657939672470092
2020-07-07,undervalued covid play,MRK,0.9551770687103271
2020-07-07,thanks gentalmen give great info outstanding numbers strong sales happy,MRK,0.9861862659454346
2020-07-07,moved above moving average july view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9042935371398926
2020-07-07,physiomics physiomics work being cited biggest global pharma companies billion published academic research journals,MRK,0.0589320883154869
2020-07-07,csimarket dividend july pays cash dividend common,MRK,0.3399236500263214
2020-07-07,dividend july pays cash dividend common record june,MRK,0.2797161042690277
2020-07-08,dangles million team flagship foghorn therapeutics drugging shape,MRK,-0.3998985588550567
2020-07-08,ratings,MRK,0.0643954575061798
2020-07-08,zbiotech says expects government funding vaccines,MRK,0.4249116778373718
2020-07-08,enters chromatin remodeling space cancer deal foghorn dtfnvrgrub,MRK,-0.165361613035202
2020-07-08,dillonrlanius biotechinvstr msollender plausible fully compatible near certainty upfront akin rounding error,MRK,0.0322792269289493
2020-07-08,zbiotech heard them deal front loaded milestone disclosure kept anti later initial work well without pushing valuation themselves,MRK,0.9173300266265868
2020-07-08,beyondinvestor know pharma industry mostly,MRK,0.1202077716588974
2020-07-08,msollender dewdiligence bradloncar misread targets came,MRK,0.2160689979791641
2020-07-08,says expects government funding vaccines bloomberg,MRK,0.5835583209991455
2020-07-08,announces appointment organon general counsel xwoeetpjpw,MRK,0.0238207541406154
2020-07-08,says expects government funding vaccines,MRK,0.639814019203186
2020-07-08,keytruda animal business hidden machines cash used another wacc below money basically free these guys nice really brainer,MRK,0.9861003160476683
2020-07-08,regulator declined grant speedy approval keytruda lenvima liver cancer citing recent clearance another regimen,MRK,-0.8900347948074341
2020-07-08,lynparza olaparib approved germline brca mutated metastatic pancreatic cancer,MRK,0.3900069296360016
2020-07-08,eisai receive complete response letter keytruda pembrolizumab plus lenvima lenvatinib combination first line treatment unresectable hepatocellular carcinoma axnckhlrhr,MRK,0.3293625712394714
2020-07-08,wait gets better initiated study across centers ucla yale included,MRK,0.974753737449646
2020-07-08,signs cancer drug development deal foghorn therapeutics ascwgaylib,MRK,-0.1247595250606536
2020-07-08,eisaiusnews application combination keytruda lenvima treat form liver cancer rejected,MRK,-0.9788141250610352
2020-07-08,recent pancreaticcancer update uxzhrolbra,MRK,-0.035971961915493
2020-07-08,basket full good news looks time paddles shock wake,MRK,0.984535813331604
2020-07-08,nedpagliarulo rare keytruda first line liver cancer dwxsqdgprw tecentriq same,MRK,-0.5937796831130981
2020-07-08,eisai receive complete response letter keytruda pembrolizumab plus lenvima lenvatinib nippoqtbdj,MRK,0.3404214680194855
2020-07-08,being raised everyone bars door against star cancer drug after roche beat them punch,MRK,-0.0439818352460861
2020-07-08,eisai esaly receive complete response letter keytruda pembrolizumab plus lenvima combination,MRK,0.3386867046356201
2020-07-08,eisai receive keytruda plus lenvima combination first line treatment unresectable,MRK,-0.4066544473171234
2020-07-08,exclusive reaches deals roche supply covid drugs source reuters,MRK,-0.4043921530246734
2020-07-08,biostocks eisai receive keytruda plus lenvima combination first line treatment unresectable hepatocellular,MRK,0.2227542698383331
2020-07-08,jacobplieth keytruda,MRK,-0.0638666376471519
2020-07-08,latest oncology news,MRK,0.3108176290988922
2020-07-08,eisai receive keytruda plus lenvima combination first line treatment unresectable hepatocellular carcinoma,MRK,0.2874572575092315
2020-07-08,rejects accelerated approval eisai keytruda lenvima combination liver cancer yqwwlpvurh,MRK,-0.5862717628479004
2020-07-08,lynparza olaparib approved germline brca mutated metastatic pancreatic cancer,MRK,0.3900069296360016
2020-07-08,moved above moving average july view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9042935371398926
2020-07-08,full anything happen,MRK,0.7049415111541748
2020-07-08,keytruda,MRK,-0.0700888782739639
2020-07-08,eisai complete response letter combo keytruda lenvima first line treatment unresectable hepatocellular carcinoma eisai carcinoma,MRK,0.2733173370361328
2020-07-08,lynparza approved germline brca mutated metastatic pancreatic cancer,MRK,0.2440200746059417
2020-07-08,recent pancreaticcancer update uxzhrolbra,MRK,-0.0293724797666072
2020-07-08,eisai receive complete response letter keytruda pembrolizumab plus lenvima lenvatinib combination first line treatment unresectable hepatocellular carcinoma,MRK,0.3509871363639831
2020-07-08,eisai receive complete response letter keytruda plus lenvima combination first line treatment unresectable hepatocellular carcinoma,MRK,0.2843680381774902
2020-07-08,latest oncology news,MRK,0.2959749102592468
2020-07-08,directional bias report click details,MRK,-0.7779198884963989
2020-07-08,report ydjktkzmjg click sell,MRK,0.2802823483943939
2020-07-08,astrazeneca lynparza wins approval pancreatic cancer bjscolbbjk,MRK,0.4004863500595093
2020-07-09,animal health announces approval bravecto chews jqhiabyfqb,MRK,0.1009363681077957
2020-07-09,animal health chews fleas ticks,MRK,-0.0311908051371574
2020-07-09,amazing oncology division underwhelming dividend opportunity rhlbjanivd,MRK,0.9889703989028932
2020-07-09,animal health receives approval bravecto fluralaner chews,MRK,0.1466595232486724
2020-07-09,swinging long,MRK,0.2708673775196075
2020-07-09,animal health receives approval bravecto fluralaner chews,MRK,0.1448948681354522
2020-07-09,click read latest merckah news,MRK,0.3487266898155212
2020-07-09,click read latest merckah news,MRK,0.34400075674057
2020-07-09,animal health gets approval bravecto chews,MRK,0.4481128454208374
2020-07-09,animal health gets approval bravecto chews,MRK,0.3285722136497497
2020-07-09,what does arqule bought beginning company pursued business strategy raising,MRK,0.8094543218612671
2020-07-09,cancer mostly blood cancer asking priority review hematological,MRK,-0.3398754894733429
2020-07-09,teams cancer startup foghorn deal meds against transcription factor target treat broad range cancer patients,MRK,0.1419236361980438
2020-07-09,grants priority review supplemental biologics license application keytruda pembrolizumab,MRK,0.0175753682851791
2020-07-09,nice deal foghorn strategic collaboration cancer million marks foghorn first partnership major pharma company cancer,MRK,1.004910945892334
2020-07-09,gives priority review keytruda treating certain patients classical hodgkin lymphoma,MRK,0.0654253289103508
2020-07-09,grants priority review supplemental biologics license application keytruda pembrolizumab second line treatment patients relapsed refractory classical hodgkin lymphoma gooqrvcqxq,MRK,0.0217947512865066
2020-07-09,amazing oncology division underwhelming dividend opportunity finance stockmarket,MRK,0.9888274669647216
2020-07-09,pain maturity maxpain options,MRK,-0.0531261041760444
2020-07-09,nabs accelerated review keytruda second line,MRK,0.0615119412541389
2020-07-09,grants priority review supplemental biologics license application keytruda pembrolizumab,MRK,0.0588383004069328
2020-07-09,nabs accelerated review keytruda second line,MRK,0.0620414763689041
2020-07-09,healthcarebeat nabs accelerated review keytruda second line,MRK,-0.0048439651727676
2020-07-09,nabs accelerated review keytruda second line,MRK,-0.0191910490393638
2020-07-09,sbwcws grants priority review sbla keytruda,MRK,0.0048105306923389
2020-07-09,biostocks grants priority review sbla keytruda second line treatment patients relapsed refractory class,MRK,-0.0196543149650096
2020-07-09,grants priority review sbla keytruda second line treatment patients relapsed refractory classical hodgkin lymphoma pdufa,MRK,-0.0199713520705699
2020-07-09,learn about recent bloodcancer update jxlucwpyog,MRK,0.2244220525026321
2020-07-09,learn about recent bloodcancer update jxlucwpyog,MRK,0.1062134653329849
2020-07-09,grants priority review sbla keytruda,MRK,0.0202809497714042
2020-07-09,moved above moving average july view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9042935371398926
2020-07-09,eisai receive complete response letter keytruda pembrolizumab plus lenvima lenvatinib combination first line treatment unresectable hepatocellularcarcinoma,MRK,0.2512507438659668
2020-07-09,lynparza approved brcamutated metastatic pancreaticcancer,MRK,0.131746232509613
2020-07-09,syinvesting foghorn entered collab foghorn proprietary gene traffic control product platform discover,MRK,-0.0284761600196361
2020-07-09,foghorn entered collab foghorn proprietary gene traffic control product platform discover develop oncology assets against transcription factor target foghorn receive undisclosed upfront milestones,MRK,0.107005089521408
2020-07-09,short interest declines,MRK,-1.0636379718780518
2020-07-09,short interest declines,MRK,-1.0509878396987915
2020-07-09,announces appointment organon general counsel,MRK,0.0487966164946556
2020-07-09,nxarria haha truly growth portfolio because these discounts example wacc which nuts think about,MRK,1.010918378829956
2020-07-09,ducksonducks shows association fact failed bace inhibitor trial load generated wors,MRK,-1.0982829332351685
2020-07-10,blazes through segment biomarker trail colorectal cancer pharma,MRK,0.0518920421600341
2020-07-10,interest volume diff purchase,MRK,0.0048712827265262
2020-07-10,sold didn move news cutting losses,MRK,-1.0717140436172483
2020-07-10,interest volume diff purchase,MRK,0.1463353931903839
2020-07-10,article sums feel about zgetydozpv,MRK,0.0426213443279266
2020-07-10,ratings,MRK,0.0643954575061798
2020-07-10,pdufa date link calendar,MRK,0.1633609384298324
2020-07-10,pdufa date link calendar,MRK,0.1376572996377945
2020-07-10,updated analysis potential collab high time frame than hoped,MRK,0.8932391405105591
2020-07-10,short interest declines,MRK,-1.0509878396987915
2020-07-10,short interest june,MRK,-0.9697263240814208
2020-07-10,short interest declines,MRK,-1.0509878396987915
2020-07-10,application first clinical trial prophylactic vaccine against sars entered backlog applications france sponsoring institutpasteur themis candidate using measle vector gepjsgktyo,MRK,0.2006903737783432
2020-07-10,animal health chews fleas ticks hzbkkdxwbd,MRK,-0.0311908051371574
2020-07-10,uptrend moving average convergence divergence macd histogram crosses above signal line view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.9489938020706176
2020-07-10,forte capital stake,MRK,0.1319351494312286
2020-07-10,healthcarebeat animal health receives approval bravecto chews,MRK,0.1942182183265686
2020-07-10,animal health receives approval bravecto chews,MRK,0.1444807946681976
2020-07-10,animal health chews fleas ticks dcxwgnsuet,MRK,-0.030071273446083
2020-07-10,bravecto chews dogs puppies weeks older merckanimalhealth msdanimalhealth,MRK,0.0314089022576808
2020-07-10,sbwcws animal health gets approval bravecto chews,MRK,0.1803895086050033
2020-07-11,declines approve eisai liver cancer combo therapy,MRK,-0.7229503393173218
2020-07-11,great discussion bloomberg wanna asset possible exceptionally ethical company working good,MRK,0.9806350469589232
2020-07-11,grants priority review supplemental biologics license application keytruda second line treatment pkbsekhjuw,MRK,-0.0265731066465377
2020-07-11,swingtradebot technical alerts handle resistance,MRK,-0.2713370025157928
2020-07-11,technical alerts handle resistance,MRK,-0.1881423890590667
2020-07-11,enters uptrend because momentum indicator exceeded level june view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8955531120300293
2020-07-11,short interest drops lywuquyayg,MRK,-1.0218045711517334
2020-07-11,short interest drops jnhcxppfgg,MRK,-1.0218045711517334
2020-07-12,ratings dktwffcyhv,MRK,0.0643954575061798
2020-07-12,enters uptrend momentum indicator exceeded level june view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8999468088150024
2020-07-12,vigilant capital management sells,MRK,-0.6313828229904175
2020-07-13,after crazy science signs partner hunt cure,MRK,-0.9570531845092772
2020-07-13,village tribsman friday raise well darivatives wide lift,MRK,0.9465959072113036
2020-07-13,areas need virus thats easy cancer unmet treatments heath needs important well,MRK,0.9401566982269288
2020-07-13,kicking earnings thur change dynamicks health segment large amount directed goverment sectore raise,MRK,0.1929899007081985
2020-07-13,collaberat together better shot lead movement including pharmas thoughts glta,MRK,0.8163506984710693
2020-07-13,players winners life saving treatments,MRK,0.9925264120101928
2020-07-13,sector move across board realize beat what important shine come back players funding bios,MRK,0.8080834150314331
2020-07-13,moderating discussion cancer drug development prior panel hear rick pazdur johns hopkins elizabeth jaffee eric rubin,MRK,-0.0706865713000297
2020-07-13,phase study gefapixant adult participants chronic cough estimated primary completion date,MRK,-0.1637202650308609
2020-07-13,phase evaluation safety tolerability immunogenicity varivax healthy russians estimated primary completion date,MRK,0.874871015548706
2020-07-13,phase pembrolizumab untreated extensive sclc estimated primary completion date,MRK,-0.012489728629589
2020-07-13,phase phase study combination capecitabine radiotherapy rectal cancer estimated primary completion date,MRK,-8.555874228477478e-05
2020-07-13,phase praziquantel orodispersible tablets schistosoma infected children estimated primary completion date,MRK,-0.1054522171616554
2020-07-13,enters uptrend momentum indicator exceeded level june view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8999468088150024
2020-07-13,chrisrandone failed ccam because dosage miss which decided stop clinical development,MRK,-1.086559176445007
2020-07-13,know partnershup close million which,MRK,0.5237104892730713
2020-07-13,know partnershup close million which prime position take look insitutuonal buying insider buying alone telll parabolic,MRK,0.9644126892089844
2020-07-14,phase phase gemcitabine small cell lung cancer nsclc estimated primary completion date,MRK,-0.1229215711355209
2020-07-14,phase randomized phase study eribulin mesylate without pembrolizumab metastatic hormone receptor positive breast cancer estimated primary completion date,MRK,0.5571764707565308
2020-07-14,phase phase blinatumomab pembrolizumab adults relapsed refractory cell acute lymphoblastic leukemia high marrow lymphoblasts estimated primary completion date,MRK,0.1634007543325424
2020-07-14,phase phase pembrolizumab idelalisib lung cancer study estimated primary completion date,MRK,-0.0559168346226215
2020-07-14,phase grapiprant pembrolizumab patients advanced progressive colorectal cancer estimated primary completion date,MRK,0.4094700515270233
2020-07-14,phase phase safety tolerability pembrolizumab pegylated interferon alfa pembrolizumab ipilimumab participants advanced melanoma renal cell carcinoma keynote estimated primary completion date,MRK,0.2802696526050567
2020-07-14,phase pharmacokinetics study pediatric participants gram negative infections estimated primary completion date,MRK,-0.2046203315258026
2020-07-14,phase safety efficacy pembrolizumab combination cisplatin oxaliplatin first line chemotherapy gastric cancer keynote estimated primary completion date,MRK,0.3949871957302093
2020-07-14,says raising covid vaccine hopes grave disservice report href,MRK,-1.0092467069625854
2020-07-14,rising volume appearances since close days later worst best days later worst best days later worst best,MRK,-0.1785763204097747
2020-07-14,receives consensus rating analysts,MRK,0.8333829641342163
2020-07-14,receives consensus rating analysts,MRK,0.8333829641342163
2020-07-14,support,MRK,0.881486177444458
2020-07-14,,MRK,0.6672643423080444
2020-07-14,expiration maxpain high open interest high call open interest,MRK,0.9279537200927734
2020-07-14,options flow grid update optionstrading optionsflow stockmarket healthcare,MRK,0.7472858428955078
2020-07-14,hackensack meridian announce covid research collaboration,MRK,0.0252648741006851
2020-07-14,donnayoungdc kenneth frazier ultimately vaccine billions people better know what,MRK,0.0559086501598358
2020-07-14,kenneth frazier ultimately vaccine billions people better know what vaccine does vaccines pharma biotech,MRK,0.161972627043724
2020-07-14,itronics itro provides update auric fulstone polymetallic gold exploration project,MRK,0.1552860289812088
2020-07-14,ratings aanavypixq,MRK,0.0643954575061798
2020-07-14,moving average broke above moving average july view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8901073932647705
2020-07-15,chitranawbatt frazier speak harvardhbs commit broad equitable affordable access matter,MRK,0.5526634454727173
2020-07-15,frazier speak harvardhbs complacent status complicit racism status generates leadership management business money hbsalumni,MRK,-0.827491044998169
2020-07-15,frazier speak harvardhbs society good enough subtle messages young africanamericans measure psychological armor defend oneself racism around leadership management business money hbsalumni,MRK,-0.7908580303192139
2020-07-15,frazier speak harvardhbs society good enough subtle messages young africanamericans measure psychological armor defend oneself racism around leadership management business money hbsalumni,MRK,-0.7908580303192139
2020-07-15,frazier speak harvardhbs complacent status complicit racism status generates leadership management business money hbsalumni,MRK,-0.7274576425552368
2020-07-15,donnayoungdc pivotal study antiviral letermovir primary endpoint cytomegalovirus,MRK,0.0125753805041313
2020-07-15,does realize covid companies longs general public,MRK,-0.072677195072174
2020-07-15,megtirrell interesting pretty definite timing valent pneumococcal vaccine,MRK,0.9376838207244872
2020-07-15,first line second nprjnmldjz,MRK,0.1889620572328567
2020-07-15,davidmarchorn doesn talk vaccine earth dump,MRK,-1.047502875328064
2020-07-15,ratings,MRK,0.0643954575061798
2020-07-15,doesn talk vaccine earth dump,MRK,-1.0605716705322266
2020-07-15,hedgeyehc know terms says raising covid vaccine hopes grave disservi,MRK,-0.115695983171463
2020-07-15,moved above moving average july view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.904301643371582
2020-07-15,know terms says raising covid vaccine hopes grave disservice report,MRK,-0.2952554523944855
2020-07-15,says raising covid vaccine hopes grave disservice report,MRK,-0.8999133110046387
2020-07-15,wolfofmstreet early agree fail stop people hopes tell them truth realistic timelines expectations beat hell those goals despise method overpromising setting fail,MRK,-1.0285329818725586
2020-07-15,stocknewstimes receives consensus rating analysts,MRK,0.8614242076873779
2020-07-15,datatrials phase phase gemcitabine small cell lung cancer nsclc estimated primary completio,MRK,-0.0659948289394378
2020-07-15,avidresearch sure what implying cases,MRK,-0.3094272911548614
2020-07-15,sure what implying cases,MRK,-0.2179615199565887
2020-07-16,chrisrandone either great news,MRK,0.9713643789291382
2020-07-16,high range option expiration putcallratio maxpain options nzxawarajv,MRK,0.9676101207733154
2020-07-16,expiration maxpain high open interest high call open interest,MRK,0.92890465259552
2020-07-16,keytruda selling drug worldwide sales forecast almost double closest rival download free copy evaluatepharma world preview find oncology anityejooe,MRK,0.6671338081359863
2020-07-16,recent technical alerts handle plus alerts,MRK,0.4000898599624634
2020-07-16,grants priority review drug application vericiguat,MRK,0.1225637346506118
2020-07-16,oncorus announces clinical trial collaboration evaluate combination oncorus oncr keytruda pembrolizumab,MRK,0.0143978409469127
2020-07-16,biostocks grants priority review vericiguat pdufa,MRK,0.0496768169105052
2020-07-16,exercises option license preclinical program star collaboration,MRK,0.2470627427101135
2020-07-16,announces clinical trial collaboration agreement oncorus oncr,MRK,-0.0026245787739753
2020-07-16,grants priority review drug application vericiguat,MRK,0.1225637346506118
2020-07-16,bwuic accepts application heart drug vericiguat accelerated review,MRK,0.0451072007417678
2020-07-16,accepts application heart drug vericiguat accelerated review,MRK,0.0168371610343456
2020-07-16,grants priority review vericiguat pdufa,MRK,0.0756410956382751
2020-07-16,researching paths forward people heartfailure learn about latest cardiovascular update,MRK,0.0177982896566391
2020-07-16,delayed issued press release july application based first contemporary outcomes study focused exclusively chronic heart failure patient population worsening event,MRK,-0.5487369298934937
2020-07-16,moving average crossed above moving average july view odds indicators stockmarket technicalanalysis money daytrading news,MRK,0.8948520421981812
2020-07-16,triniblockchain signed cooperation agreement,MRK,0.0874876379966735
2020-07-16,patient propecia clinical trial suffered permanent sexual dysfunction after discontinuing finasteride,MRK,-0.7910842895507812
2020-07-16,first thing course look below drug timeline process focus main drugs hepitatis influenza corona virus inhibitors start collab,MRK,-0.9511816501617432
2020-07-16,dismantle death cult known killed tens thousands people than arrestkenfrazier propecia justiceforvioxxvictims,MRK,-0.9087749719619752
